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Background: The association between Mycobacterium tuberculosis infection and 
tobacco smoking has recently been highlighted.
24 25 The reason for this association 
remains unclear, but is postulated to result from the effects of smoking on 
pulmonary host defences. Cannabis impairs the immune function of alveolar 
macrophages and has been reported to increase susceptibility to respiratory 
infections. 77 
Aim: To examine risk factors for both Mycobacterium tuberculosis disease and 
infection, in particular the effects of cannabis smoking. 
Methods: A cross-sectional population survey of 3512 persons aged ~ 15 years 
was performed in a predominantly low-income urban area of Cape Town, South 
Africa. Information on a history of tuberculosis and various risk factors including 
cannabis smoking was collected by means of an administered questionnaire. Ziehl-
Neelson stained sputum smears were examined for acid fast bacilli and cultured on 
Lowenstein Jensen slants. Tuberculin skin testing (TST) was performed and an 
induration of ~ 0mm read after 48-72 hours was considered positive. One joint year 
is defined as one joint per day for one year. 
Results: The prevalence of ever smoking cannabis was 11.3% (23% in men; 2.6% 
in women) and 6.4% were current smokers. A history of tuberculosis was reported 
by 9.7%; current disease confirmed in 1 %, and 76% had a positive TST. After 
adjusting for age, sex, tobacco smoking, income, education, occupational exposure, 
incarceration, alcohol use and body mass index, persons with a cumulative 
cannabis exposure of >70 joint years (approximately equivalent to 20 tobacco 
packyears) had an increased risk of past/current tuberculosis disease (OR 3.2; 
Cl:1.8 - 5.6). Cannabis joint years did not show an association with tuberculosis 
infection. 
Conclusions: This population study shows that cannabis smoking is positively 
associated with past/current tuberculosis disease, suggesting that cannabis may be 
a risk factor in the development tuberculous disease. 
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CHAPTER 1: INTRODUCTION 
This project was conducted in partial fulfilment of the requirements for a Master in 
Public Health degree at the University of Cape Town. It is a sub-study of a large 
multicomponent hypothesis-generating study, the Lung Health Survey 2002 
(LHS2002). The LHS2002 is a collaborative effort between the Tuberculosis 
Research group at the University of Stellenbosch (now the Desmond Tutu Centre for 
TB Research), the University of Cape Town Lung Institute and the City of Cape Town 
Department of Health. 
As an investigator, the candidate was fully involved in the conception of the study 
and formulation of the research questions, responsible for development of the 
questionnaire, training of fieldworkers and contributed to the day-to-day management 
of fieldwork, quality control, supervision of questionnaire administration and data 
capture. This mini-dissertation, including literature review, data cleaning and analytic 
strategy, all statistical analysis and data interpretation were performed by the 
candidate. 
One of the aims of the Lung Health Survey LHS2002 was "to determine the 
prevalence of other lung diseases, and the influence, if any, of co-morbidities and 
environmental factors like smoking upon lung health" (Lung Health Survey protocol). 
This mini-dissertation describes a component of this aim, namely an assessment of 
the role of cannabis smoking upon lung health, specifically tuberculosis (TB) disease 
and infection. 
1.1. Background 
Globally, tuberculosis is the second most important cause of death from infectious 
disease and the ?1h leading cause of disability adjusted life years (DAL Ys ). 1 2 Africa 
has the highest incidence of TB in the world (259/100,000).3 Much of this burden 
occurs in Sub-Saharan Africa which has an incidence of 290/100,000.3 4 
Tuberculosis has reached endemic status in South Africa, and is the third leading 
cause of premature mortality (years of life lost) in South Africa.5 
In 2000, in the Western Cape province (one of the nine provinces in South Africa) TB 
accounted for 6.8% of deaths, being the fifth leading single cause of death, and is the 
third leading cause of premature mortality in the province (7.9% of years of life lost).6 
1 
Tuberculosis was the leading cause of death in men aged over 45 years and ranked 
in the top four causes of death in females and in other age groups. 
In 2002, the Western Cape had the highest incidence of tuberculosis (917/100,000), 
and historically has always had the highest notification rate per province, even 
though in 2003 it did not have the highest number of cases (this occurred in Kwa 
Zulu Natal which has a larger population and the highest HIV prevalence).7 The TB 
epidemic in the Western Cape at the time of this study was thought not to be driven 
by the HIV epidemic, having preceded it. The HIV prevalence rate in the study area 
(Western Tygerberg region) was relatively low (7.9%) in 2001 but, as expected, had 
risen to 15.1 % by 2004.i It is still however lower than in other areas of Cape Town 
such as Khayelitsha (33%) and most other provinces. 8 
Since the industrial revolution in Britain in the 1800's, the causes of tuberculosis have 
been sought. Following Koch's discovery of the tubercle bacillus one hundred years 
ago and with the advent of antimicrobials in the 1950's, the treatment of tuberculosis 
has improved. However, the important contributory causes of the epidemic include 
poor living conditions and other factors that weaken host defences. Many of these 
factors have been identified and most are aggravated by poverty. Despite the 
widespread availability of drugs, these poverty-related factors persist and drive the 
epidemic onwards. 
The reason for the high transmission rates, prevalence and incidence of tuberculosis 
in the Western Cape Province, and particularly in Cape Town have not been fully 
elucidated, and both host and/or bacterial factors may be responsible.9 One of these 
is tobacco smoking, reported to be 57% in men and 40% in women, being the 
second highest provincial rate in South Africa, with predominantly low to moderate 
consumption of 1-14 cigarettes per day. 10 
Cannabis smoking is a common practice in Cape Town, but there are few data on its 
prevalence and attendant consequences. Recent publications from other parts of the 
world have linked cannabis to outbreaks of tuberculosis81 85 87 , but the mechanisms 
and factors underlying this association are not clear. Tobacco smoking has also been 
identified as a risk factor and this begs the question as to whether cannabis smoking 
i 
HIV prevalence was measured in pregnant females aged 15-45 years, attending public service antenatal facilities, 
thought to be a higher risk group. General population prevalence is assumed to be lower. 
2 
could also be a potential independent risk factor for tuberculosis, considering the 
similarity of constituents. 
Over the past few decades, risk factors for tuberculosis that have been identified in 
various studies worldwide include low socioeconomic status (measured by various 
indicators such as income, education, occupation etc), HIV infection, male sex, older 
age, ethnic groups in certain geographical areas, homelessness, crowding, known 
TB contacts, intravenous drug abuse, tobacco smoking, heavy alcohol use, low 
weight for height, foreign birthplace, residence in hostels and prisons and residential 
segregation. 11 12 13 Cannabis has only recently been associated with tuberculosis in 
outbreak investigations, and very few data are available as yet. 
1.2. The Lung Health Survey 2002 
Ravensmead and Uitsig, two adjacent suburbs of Cape Town in the Western Cape 
Province, are distinguished by a prevalence of tuberculosis that is amongst the 
highest in the world estimated at 10 per 1000 population and a case notification rate 
for adults aged ~15 years of 1029/100,000. 14 15 Recognised associations of 
tuberculosis are with urban poverty related to crowding, poor nutrition etc; and the 
association of TB with tobacco smoking. These two suburbs also have very high 
rates of tobacco exposure of 67% in men and 50% in women. 16 The incidence of 
tuberculosis had increased despite having 'moderate quality' Tuberculosis Control 
programme as rated by the World Health Organisation (WHO) Stop TB 
Programme. 17 
Partly in response to this increase, the University of Stellenbosch TB Research Unit 
(now the Desmond Tutu TB Research Centre) in collaboration with the UCT Lung 
Institute developed a multi-component survey of Ravensmead and Uitsig. This study, 
the Lung Health Survey 2002 (LHS2002) aimed to establish the prevalence and risk 
factors for tuberculosis and other common respiratory symptoms and lung diseases 
by means of a population survey. 
The LHS2002 provided an opportunity to study the relationship of tuberculosis with 
various environmental risk factors. The relationship between TB and cannabis 
smoking is addressed here. 
3 
The initial survey was followed by three separate Part Two studies, performed 
independently by different investigators. The first was a study of children examining 
the associations between asthma and allergy and tuberculosis, and the influence of 
environmental factors on allergic disease.
18 The second study assessed the 
prevalence and risk factors for asthma in young adults (aged 15 - 44 years ).
19 The 
third was a multi-country initiative known as the Burden of Obstructive Lung Disease 
(BOLD) study that aimed to assess the prevalence and risk factors for Chronic 
Obstructive Pulmonary Disease (COPD).
20 
1.3. Mini-dissertation aim and objectives 
Aim: 
To assess cannabis smoking as a risk factor for both tuberculosis infection and 
tuberculosis disease in a high tuberculosis prevalence, predominantly low-income 
urban area of Cape Town, South Africa. 
Objectives: 
1. To briefly and selectively summarise the literature on risk factors for 
tuberculosis. 
2. To review the literature on cannabis smoking in relation to tuberculosis. 
3. To analyse the association of cannabis smoking as a risk factor for 
tuberculosis infection and disease in the presence of other risk factors such 
as socioeconomic status, education, tobacco smoking, alcohol abuse, 
occupational exposures and incarceration. 
1.4. Thesis structure 
This introductory chapter provides some general background on tuberculosis in 
South Africa and outlines the aim and objectives of this mini-dissertation. Chapter 
Two is a brief, selective literature review on the risk factors for tuberculosis, with 
special reference to the role of cannabis smoking. Chapter Three provides details of 
the methods of the LHS2002. Chapter Four presents the results of the study in the 
form of some descriptive tables and an analysis of the outcomes with various risk 
factors. These results are discussed in Chapter Five. 
4 
1.5. Nomenclature and definitions 
The following definitions have been used for the purposes of this study: 
Tuberculosis infection is defined as a tuberculin skin test (TST) of ~10mm diameter 
read between 48-72 hours. 
Tuberculosis disease is defined as past and/or present tuberculosis (see below). 
Past tuberculosis is defined as questionnaire-based self-reported history of 
tuberculosis (see Appendix 2, Question 17). 
Present tuberculosis is defined as bacteriologically confirmed tuberculosis. 14 
Bateriologically confirmed tuberculosis is defined as: 
two smears positive for acid fast bacilli or two positive cultures from different 
sputum samples OR 
A positive smear and a positive culture from different samples or from the 
same sample OR 
Either one positive smear or a positive culture with 
a) TB related abnormalities on the chest radiograph OR 
b) A positive smear or culture from sputum samples collected within two 
months of the sputum sampling for the Lung Health Survey 
The Vancouver referencing method is used.21 
5 
CHAPTER 2: LITERATURE REVIEW: SELECTED RISK 
FACTORS FOR TUBERCULOSIS 
2.1. Introduction 
The aim of this chapter is to selectively review certain risk factors for tuberculosis, 
with special reference to the role of cannabis smoking. Since there is little literature 
on cannabis smoking and tuberculosis, this part of the review is brief. However, much 
of the literature on tobacco smoking and tuberculosis is relevant in terms of 
examining the practice of smoking itself, and potential common mechanisms involved 
in the risk of tuberculous infection and disease associated with tobacco and 
cannabis. 
For over two centuries, poverty-related risk factors for TB have been clear. Some of 
these factors continue to remain, especially in developing countries. Low 
socioeconomic status, poor living conditions, overcrowding and exposure to TB 
patients are factors for which there is most certainty. However, epidemiological 
research over the last two decades has provided evidence of several other risk 
factors. 
Known associations with tuberculosis are listed in Table 1, grouped according to the 
current evidence for the certainty of the association. In addition to cannabis smoking, 
risk factors that are associated with the inhalation of particulate matter are reviewed; 
viz. tobacco smoking and indoor air pollution. The large literature on other known risk 
factors will not be addressed here. 
6 
Table 1: Known associations with tuberculosis 








Certain occupational exposures 
e.g. mining (silicosis) 
Tobacco smoking 




Living conditions (crowding) 







HIV infection, anergy, low CD4 count22 
BMI/ malnutrition 
Comorbidities causing immunosuppression: 
e.g. renal failure, malignancy, diabetes, 
transplant, drugs (cortico-steroid use) etc. 
Family history of TB 
Indoor air pollution (Biomass fuel) History of asthma (protective) 
Environmental Tobacco Smoke Childhood respiratory infection 
(in children) 
Other occupational exposures 
Outdoor air pollution Genetic predisposition 
Cannabis smoking 
The association of tobacco smoking and tuberculosis has been established in many 
studies. Two recent meta-analyses by Lin et al (2007) and Bates et al (2007) 
summarise and comment on the association between tobacco smoking and TB 
disease, TB infection and TB mortality. 24 25 A modified version of information from 
case control and cross sectional studies reviewed in these publications are presented 
in Tables 2 and 3. These list studies of tobacco as a risk factor either for tuberculosis 
disease (Table 2) or for tuberculosis infection (Table 3). Population based studies 
related to TB disease and TB infection are of particular relevance. 
7 
Bates et al report risk ratios for TB disease of between 2.3 and 2.6. Studies of 
pulmonary TB (as opposed to any TB) consistently confirm a higher risk of TB 
disease with tobacco smoking. 24 Several mechanisms of disease causation have 
been suggested of which a decreased immune response demonstrated as CD4 
lymphopaenia, defects in macrophage immune responses, and mucociliary 
dysmotility are examples.26 25 
Ever smokers have a lower risk than current smokers (OR 2.3 - 2.6 vs. 2. 7), 
suggesting that smoking cessation may reduce the risk of TB disease.25 As with most 
studies examining smoking as a risk factor, misclassification can be a problem, as 
can confounding by variables that are not included in the multivariate analysis, such 
as alcohol. Therefore, examining multiple studies that have adjusted for various risk 
factors increases confidence in the association with smoking (see "other variables" in 
Table 2). 
There seems to be consistent epidemiological evidence to suggest that tobacco 
smoking is associated with TB. Most of this data comes from China, the United 
Kingdom, India and the United States (see Tables 2 and 3) with the earliest 
association published in 1956 by Lowe et al. 52 The only longitudinal cohort study was 
that of British doctors by Doll et al ( 1994) which found that smokers were three to 
four times more likely to develop TB than non smokers, and three times more likely to 
die of pulmonary TB than their non-smoking counterparts. 27 Despite being based on 
small numbers of persons with the outcome, this finding supports the evidence from 
cross sectional and case control studies. 
Several studies found evidence of dose response relationships between tobacco 
smoking (amount per day and duration in years) and both TB disease and infection. 
This is evident in the study by Kollapen et al (2002) (see Table 2). 43 Alcaide et al 
( 1996) performed a case control study compared persons with active tuberculosis 
disease (cases) to others with a positive tuberculin test and no clinical, 
bacteriological or radiographic evidence of tuberculosis (controls).48 They found a 
dose response relationship with tobacco smoking as a risk factor for tuberculosis 
disease. Other factors (apart from the dose response relationship) that have been 
associated with an increased risk of pulmonary tuberculosis in adults are early age of 
initiation of smoking, smoking for >1 O years and passive smoking. 28 
8 
Latent TB appears not be confined to the primary lesions in the lungs. As early as 
1927 it was noted that mycobacteria could be cultured from histologically normal 
tissue from the same lungs, even though the primary lesions had become sterile.29 It 
is thought that nicotine leads to the reactivation of latent TB by decreasing levels of 
TNF-alpha production by alveolar macrophages.30 Since TNF- alpha is essential for 
maintaining the latent state of TB bacilli within macrophages, reactivation may occur. 
Another effect of nicotine is that it allows macrophages to survive for prolonged 
periods by reducing apoptosis, which promotes the killing of mycobacteria. 31 32 
The importance of considering smoking as a risk factor for tuberculosis is that it has 
one of the greatest potentials for modification, particularly in high TB prevalence 
regions. In addition, acceptance of tobacco smoking as a risk factor for tuberculosis 
has implications for the assessment of global tobacco related mortality. For example, 
Bates et al have reported that 31 % of TB cases are attributable to tobacco 
smoking.25 
TB infection 
A summary risk ratio for TB infection was found to be 1. 7 (95% Cl: 1.5 - 2.0) in the 
meta-analysis by Bates et al (2007).25 Lin et al reported a pooled odds ratio of 2.0 
(95% Cl: 1.5 - 2.8) when using a 5 mm TST cut-off and 1.8 when using a 10mm 
cutoff. 24 A point to note is that the two studies that adjusted for alcohol reported lower 
odds ratios than those that did not, suggesting that alcohol is a significant confounder 
to the relationship between TB infection and tobacco smoking. 
In a study of Lebanese prisoners, Adib et al found that a longer duration of 
incarceration was associated with an increased risk of TB infection.60 The association 
with smoking in this study was weaker than studies that were not performed in prison 
populations or did not adjust for incarceration in their analyses (OR = 1.2; Cl: 1.1 -
1.3). A limitation of not adjusting for other known risk factors in multivariate analyses 
may mean that confounders were not fully accounted for (see Table 3). 
Another prison-based study by Anderson et al (1997) found a positive signal between 
smoking and TB infection but results were not all significant at the 5% level. They 
suggested that the cumulative effects related to the duration of smoking may have 
been more important than the number of cigarettes smoked. The only study that 
examined a cumulative exposure variable for tobacco smoking was den Boon et al 
9 
who observed a dose response related to increasing packyear exposures (packyears 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3. Environmental tobacco smoke (passive smoking) 
It is well known that passive smoking ( environmental tobacco smoke) is a risk factor 
for respiratory symptoms and illnesses in children. 61 However passive smoking has 
only recently been considered a potential risk factor for tuberculosis. 
A Spanish study by Altet et al ( 1996) examined TST positive household contacts of 
TB cases and compared contacts that became cases (93 cases) to those contacts 
that did not become cases (95 controls).62 A dose-response relationship was found 
between the risk of developing TB immediately following infection and the number of 
cigarettes smoked daily by adults in the home. Younger children were at greater risk 
than those 2!10 years of age. Passive smoking was strongly associated with TB 
(adjusted OR 5.39; 95% Cl: 2.4 -11.9). An increased risk was present in children 
exposed both within and outside the home (OR: 6.35; 95% Cl: 3.2 - 12.7). 
Statistically significant differences in urinary cotinine levels were found between 
contacts with TB disease and contacts without TB disease. 
Another two case control studies from Thailand have confirmed the association of 
passive smoking with tuberculosis disease. Tipayamongkholgul et al (2005) found 
that risk of TB was nine times greater in children who had close and very close 
contact with smoking household members (OR 9.3; Cl: 3.1 - 27.6).63 Ariyothai et al 
(2004) examined passive smoking in adults and showed that exposure in the home 
and the workplace for >3 days a week increased the risk of pulmonary TB 
considerably (OR 4.6, 95% Cl: 1.7-15.0). 
Passive smoking was also associated with an increased risk of tuberculosis infection 
in a study of children under 5 years (OR 2.7; Cl 1.5 - 4.7) in a hospital-based study 
from lndia.64 A suggested mechanism is that tobacco smoke impairs pulmonary 
defence mechanisms but the authors also suggest that smoking may also reflect 
poorer health related habits and behaviour that may independently increase the risk 
of infection. However they confirm that their study suggests an independent 
association of passive smoking with tuberculosis infection. 
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2.4. Indoor air pollution/Biomass fuel 
Indoor air pollution is a relatively newly identified risk factor for tuberculosis and only 
five published studies have addressed its contribution to tuberculosis disease. 
Mishra et al (1999) was the first to report an association in a study of 260,000 
persons aged >20 years of age in the National Family Health Survey of India 
reporting an OR of 2.58 (95% Cl: 1.98-3.37).65 The authors adjusted for many risk 
factors such as the availability of a separate kitchen, house type, indoor crowding, 
age, gender, urban or rural residence, education, religion, caste or tribe, and 
geographic region. Notably tobacco smoking was not one of the variables 
considered. The attributable fraction of biomass fuel exposure as a risk factor for 
tuberculosis in India was significant, calculated to be 51 %. 
A recent smaller case control study from India did not find an association with 
biomass fuels, however it is possible that the study lacked the power to demonstrate 
this association.66 Both biomass fuels and tobacco smoking were significant in the 
univariate analyses only. 
A case control study by Perez Padilla et al (2001) found the odds of current biomass 
fuel exposure to be 5.2 (95%CI 3.1-8.9), whereas past or present exposure was 3.4 
(95%CI 2.4-5.0) and past exposure was 1.8 (95%CI 1.1-3.0).67 These associations 
were found in urban and suburban Mexico City, and this study adjusted for smoking 
amongst other important risk factors. Delineating the effect of poverty from the 
exposure to biomass fuels is difficult, but this study did adjust for income and 
education. The postulated mechanisms for the association of biomass smoke with 
tuberculosis are similar to those suggested for tobacco smoke, but remain unclear at 
this stage. 
The only African study (from Malawi) showed no association with biomass fuel 
exposure. 68 The authors suggest that owing to the difficulty in obtaining an accurate 
estimate of exposure, misclassification may have lead to no effect being found. In 
addition they cite that there was good ventilation of most houses. 
No studies assessing the relationship of indoor air pollution with tuberculosis 
infection could be found. 
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2.5. Cannabis 
The public health issue of cannabis smoking is of increasing significance as it 
appears to be on the increase world wide and especially in developing countries.69 
An increase in perceived risk of harm from using cannabis usually predicts a decline 
in use. 
Cannabis use is thought to have doubled in South Africa between 1990 and 2003, 
possibly due to more having expendable income, more vigorous law enforcement in 
developed economies resulting in the exploitation of the South African market, and 
increased import across open borders after 1994.70 The cost of cannabis in South 
Africa is very low and an association of cannabis smoking with duration of urban 
residence has been reported. Rapid urbanisation and its accompanying problems of 
poverty, crime and housing predisposes to cannabis and other substance abuse. 
In South Africa, a case control study of multi drug resistant tuberculosis showed that 
the strongest risk factor for defaulting tuberculosis treatment was smoking marijuana 
or methaquolone (OR 17.9, 95% Cl 4.7-68.5).71 Smoking cannabis was also ten 
times more likely in cases compared to controls. This could suggest that the prior 
history of smoking increases the risk of acquiring tuberculosis infection and 
subsequently disease. The assumption that cannabis smoking is merely associated 
with poor adherence to therapy may be just one facet of the relationship between 
cannabis smoking and tuberculosis. This relationship needs to be examined in more 
detail. 
Particularly high rates of cannabis smoking have been reported in Cape Town. 72 
Cannabis is the most commonly used illicit drug in South African adolescents. A 
significant proportion of adult patients attending a public hospital trauma unit tested 
positive for cannabis, suggesting a link with trauma and criminal activity. 72 Lifetime 
use was reported by 32% of male and 13% of female adolescents in Cape Town, 
with 21.5% of males and 8.6% of females reporting use in the past year, reflecting 
what seems to be a predominantly male phenomenon. However, reporting bias and 
underreporting need to be considered in this context. Seven percent of adolescents 
reported use in the last year.73 
As can be seen in Tables 2 and 3, there have been few population-based studies of 
risk factors for tuberculosis, and none of these have considered cannabis smoking 
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as a potential risk factor. The relationship between cannabis smoking and 
tuberculosis has been little researched, and consequently the literature is very 
scanty. If cannabis is shown to be a risk factor, it raises the question as to whether 
the risk of infection related to the products of combustion in smoke common to both 
forms of smoking or whether they relate to specific properties of each - tobacco and 
cannabis smoke. However, both the specific and common combustible by-products 
could be factors. 
Cannabis smoke shares many constituents with tobacco smoke.74 These include 
carbon monoxide, cyanide, benzene, vinyl chlorides, aldehydes, phenols, 
nitrosamines and polycyclic aromatic hydrocarbons. 74 75 Tobacco smoking has been 
shown to increase predisposition to lower respiratory tract infections, including 
tuberculosis, the same may also be true of cannabis smoking. 
Studies suggest that cannabis is an immune modulator. In vitro and animal studies 
have shown that delta tetrahydocannabinol (THC) produces several 
immunosuppressive effects on T cells, natural killer cells and macrophages and 
exposed mice were unable to develop a successful immune response against 
legionella pneumophila. 76 Clinical studies in humans which have recovered alveolar 
macrophages from the lungs of cannabis smokers showed impaired phagocytosis 
and bacteriocidal activity. In addition they displayed reduced generation of 
proinflammatory cytokines including TNF-alpha, granulocyte macrophage-colony 
stimulating factor (GM-CSF) and interleukin-6 and an inability to use nitric oxide. 77 
109 This reduction in immune function might predispose to opportunistic infections 
(and carcinogenesis) by impairing host defences against lung pathogens. The 
proposed mechanisms of immune dysfunction are discussed in detail in Chapter 5. 
These mechanisms could theoretically result in increased susceptibility to infections 
such as tuberculosis. Apart from one case report of chronic cannabis smoking 
leading to necrotising pulmonary granulomata as a result of possible fungal 
contamination of cannabis, no associations between cannabis and respiratory 
infections including tuberculosis have been confirmed.78 However, the practice of 
sharing joints and other smoking appliances (e.g. pipes) might put smokers at some 
risk of cross-infection if shared with persons with TB.79 This point may be of 
importance in the thesis study site, because social activities such as drinking alcohol 
in informal taverns (known as shebeens) have been shown to be associated with the 
spread of Mycobacterium tuberculosis.80 
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Methods of cannabis smoking associated with tuberculosis 
Cannabis water pipe smoking has been implicated as a risk factor for tuberculosis, 
when a cluster of five cases was noted by Munckhof et al (2003) in young males in 
Queensland, Australia. 81 Of those contacts who shared a cannabis water pipe with a 
case, 64% had a positive TST, compared to 50% of the total number of contacts. 
Sharing a cannabis water pipe with a TB case was associated with TB infection (OR 
2.2; 95% Cl: 1.0-5.2), but appears not to be statistically significant. It is difficult to 
ascertain whether close social contact and sharing of the pipe are the only risk 
factors or whether it is a combination of the material smoked and the former. 
Similarly, the practice of shotgunning of cannabis could also be a potential risk 
factor for tuberculosis. "Shotgunning" drugs (or "doing a shotgun") refer to the 
practice of inhaling smoke and then exhaling it into another individual's mouth, a 
practice with the potential for the efficient transmission of respiratory pathogens.82 
Riley et al (2001) found this practice to be commonly reported in a tuberculosis 
screening programme which used computer-assisted questionnaires in comparison 
with interviewer assisted questionnaires.83 An earlier report by Livengood et al 
( 1985) investigating isoniazid resistant tuberculosis found that all contacts who 
smoked cannabis (14) were TST positive.84 The small sample sizes in these studies 
preclude suggesting a causal association for cannabis but alerts to the possibility of 
one. 
More recently, Oeltmann et al (2006) reported another smoking behaviour 
associated with the transmission of tuberculosis.85 "Hotboxing" refers to smoking 
marijuana inside a closed car in order to permit repeated inhalation of cannabis 
smoke in this confined atmosphere. This practice was associated with a tuberculosis 
outbreak in adolescents in Seattle, Washington. A large proportion of the friends of 
cases (64%) had positive tuberculin skin test results. Again, both close social 
contact and the material smoked may be implicated in susceptibility to acquiring 
tuberculosis infection and disease. This practice of smoking is also relevant because 
cannabis smoking is often performed in enclosed spaces in order to avoid detection, 
and the shared airspace increases risk of transmission. 81 
In another study from Seattle, Park et al (2001) found that HIV positive patients with 
community acquired pneumonia (which included tuberculosis as a common 
19 
aetiological agent) were more likely to be cannabis users.86 Similarly, Sterling et al 
(2000) reported cannabis smoking as a common finding in 7 out of 20 infected 
persons in a TB outbreak. Other risk factors such as HIV infection were also 
common in this group.87 
None of the papers linking cannabis smoking with tuberculosis infection have 
suggested that the constituents of cannabis itself or the smoking of cannabis could 
have been risk factors on the basis of immunosuppression, as is suspected with 
tobacco smoking. This is probably because all these studies were case series which 
would not allow for the assessment of cannabis exposure as a risk factor for 
tuberculosis. No studies have assessed this risk at a population level or even as 
case control studies. Considering the growing literature on the association of 
tobacco smoking and tuberculosis, it is plausible that cannabis smoking may 
likewise be associated with tuberculosis. 
The second most commonly abused drug in Cape Town is known as a "white -
pipe". This refers to methaquolone (a non-barbiturate sedative hypnotic), cannabis 
and tobacco smoked in any combination or each alone, using a makeshift pipe 
fashioned from a broken bottle neck (see Figure 1 ).88 This form of drug abuse 
appears to be unique in South Africa. It is suspected that the true prevalence of 
cannabis smoking and methaquolone usage may be higher than that reported 
because self-reported usage is likely to be understated owing to the illegal status of 
the drugs. There are no South African data on the effect of cannabis smoking on 
respiratory health in terms of the risk of tuberculosis infection or disease. 
Figure 1: "White pipe" method of smoking cannabis in a makeshift 
"pipe" fashioned from a broken bottle neck88 
(With kind permission from H. Donson) 
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The percentage of cannabis smokers that will develop TB infection and TB disease 
is not known. Quantifying exposures may be difficult, limiting dose-response 
analyses in population studies. The different methods of smoking cannabis, different 
sizes of cigarettes or pipe volumes, the tendency for joints to be shared, unreliable 
self-reporting, varying puff volumes, differing retention times and filtering all pose a 
challenge to the assessment of associations.89 
A particularly important factor in the quantification of cannabis use is underreporting. 
This may cause a significant bias in countries where cannabis is illegal, and is 
discussed further in Chapter Five. 
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CHAPTER 3: METHODS OF THE LUNG HEAL TH SURVEY 
The LHS 2002 was a cross-sectional study of the population of the adjacent suburbs 
of Ravensmead and Uitsig involving a 15% random sample of addresses and 
recruiting non-institutionalised persons aged ;::15 years living at the sampled 
addresses. The methods of the Lung Health Survey have been described in detail 
elsewhere, and are adapted here.55 90 
3.1. Study area and study population 
The study was performed in two adjacent predominantly low-income suburbs of 
Cape Town, known as Ravensmead and Uitsig. These suburbs originated from the 
forced relocation of persons classified as "coloured" by the apartheid/segregation 
policy of the Nationalist government known as the Group Areas Act in the 1960s. 
Poor housing is characteristic of this area, ranging from small informal backyard 
shacks to single storey free standing homes with gardens, and poorer 'flats' or 
apartment blocks with access to facilities. Often the primary home owners or lessors 
charge rent for backyard shacks/buildings which are overcrowded with an average 
of 4.1 rooms and an average household size of 7-10 persons.91 Thirty six percent of 
the population lives in these dwellings which often are not connected to water, 
electricity or sewage facilities. Unemployment is high with only 36% of the 
population (;::15 years of age) employed in the formal sector. Forty seven percent of 
the population have an education of less than Grade seven. 90 
The population pyramid of these suburbs resembled that of a developing country 
with a high proportion of persons in the younger age groups - forty percent of the 
population was less than 20 years and 30% less than 15 years. The largest number 
of persons fell into the 25-34 year age group (>7000). Poverty was a feature with 
67% of the population earning less than R3500 in 1996. The TB notification rates 
had been steadily rising over the past few years from 228 per 100,000 in 1994 to 
299 per 100,000 in 1998 and 341 per 100,000 in 2002.92 93 100 In view of this 
increasing prevalence of reported tuberculosis and anecdotal evidence of a high 
prevalence of cannabis smoking, Ravensmead and Uitsig was an appropriate site in 
which to investigate risk factors for tuberculosis. 
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3.2. Study design 
This was a cross sectional population study. 
3.3. Sampling 
In 2001, Ravensmead and Uitsig had a population of 36,334 living in 5,592 
households. The 1996 South African Population Census districts with enumerator 
sub-district (ESD) boundaries were used as a sampling frame. Geographical 
Information System (GIS) mapping which combines aerial photography, computer 
graphics and existing information in order to create a comprehensive map of the 
area was used. Each location was assigned a specific land-use.94 The resultant map 
detailed flats (apartments), houses and non-residential areas. The non-residential 
areas included open spaces, sports fields, churches, town halls, community centres, 
clinics, schools, shops, businesses and parking areas (see Figure 2). 
The primary sampling unit or cluster was an address. This could be either a physical 
street address (name and number) or the name and number of a flat. A list of 
addresses was obtained from the local municipality. 
Of the total number of addresses, 656 (11.73%) were flats (apartments) and the 
remaining 4,936 (88.27%) were houses (single storey dwellings, some semi-
detached). The number of persons per address in flats and houses was very similar, 
and ranged from 6.63 to 13.83 in flats and 5.5 - 12.9 in houses. The random sample 
comprised 839 addresses which was a 15% simple random sample of all addresses 
(see Figure 2). 
Trained community workers enumerated the occupants in each selected residential 
address, i.e. a new household census was performed prior to the data collection in 
order to accurately update the 1996 census information, which had been performed 
six years prior to the study. A 'dwelling questionnaire', completed for each dwelling 
at each residential address, collected demographic details of all residents, e.g. age 
and sex. A dwelling was defined as a place that provided shelter, cooking, washing 
and sleeping facilities. A household was defined as a house and any associated 
informal dwelling or dwellings at the same address or on the same plot of land, i.e. 
all residents at each address.95 
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During the re-enumeration census, consent was sought from persons residing at 
each address. If the head of the household did not give consent for the household to 
be included, the address was replaced by a neighbouring address according to a 
fixed rule. The sampled house was replaced by a house to the right of it, and if that 
household refused, by the house to the left of the sampled household. This process 
was continued until a household willing to participate was located. Written informed 
consent was requested from all participants. The total number of potential 
participants was 3971 persons. 
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Figure 2: Location of addresses where TB had occurred in relation to the 
random sample of addresses for the study 
3.4. Study procedures 
Individuals 15 years and older were assessed as follows: 
1. Informed consent 
2. Questionnaire 
3. Measurement of height and weight 
4. Tuberculin skin test 
5. Examination for the presence of a Bacille Calmette-Guerin (BCG) scar 
6. Chest radiograph 
7. Sputum sample for smear examination for acid-fast bacilli. All sputum samples 
were set up for culture on Lowenstein Jensen slants. 
25 
3.4.1. The questionnaire 
A respiratory questionnaire was developed by the candidate in conjunction with the 
project team. This was an iterative process, involving multiple revisions, and took 
approximately ten months during the planning stage of the survey. The final 
questionnaire included questions from disease-specific international questionnaires, 
such as the European Community Respiratory Health Survey (ECRHS) 
questionnaire, which had been validated elsewhere. Additional questions that had 
not been validated in other countries, for example, on exposures and symptoms of 
tuberculosis, were incorporated. Questions relating to demographic information, 
potential risk factors of interest (including confounders) and healthcare utilisation 
were compiled into a single questionnaire (See Appendix 2). Questions on past TB 
diagnosis and TB treatment, including the date of treatment/s, were asked. 
The vast majority of inhabitants spoke Afrikaans as their first language and most 
persons were bilingual, speaking English as their second language with variable 
proficiency. The local dialect of Afrikaans differs from other parts of the country in 
terms of word-use and accent. The questionnaire was thus adapted, piloted and 
translated into Afrikaans by translators familiar with the local terminology. 
Training of the fieldworkers was carried out in a three day workshop which covered 
questionnaire administration as its main component. The study background and 
objectives were presented and the interviewers were trained in basic questionnaire 
administration technique. The training involved the discussion of each question and 
role play of the study visit. This was performed individually and in small group 
sessions. The candidate and other team members critically appraised the role play 
and identified and discussed areas of concern. The need for standardisation without 
individual interpretation or explanation of questions was emphasized. 
Trained interviewers administered the questionnaire in a door-to-door household 
survey, both during and after working hours, to ensure inclusion of the working 
population. Quality control involved observation of interviewers by the project 
leaders, and scrutiny of all completed questionnaires for completeness, accuracy 
and consistency. Approximately 70% of the questionnaires were completed in July 
and August 2002, and the rest between September and December 2002. 
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3.4.2. Height , weight, Tuberculin Skin test and presence of a BCG scar 
Height was measured by asking the participant to remove their shoes and stand tall 
on a level surface, with their head, shoulders, buttocks and heels (together) firmly 
against a wall. Ensuring that the head was straightened, a headboard was placed 
firmly on top of the head at right angles to the wall, and a pencil line drawn where 
the headboard met the wall. The distance from the floor to the line was measured 
using a tape measure and recorded to the nearest 0.1 cm. Nurses were trained to 
avoid the error of parallax by ensuring that they read the height measurement in the 
same horizontal plane as the pencil mark. 
Weight measurement: Participants were asked to remove their shoes and heavy 
outer clothing and stand on a digital scale which was placed in a firm flat surface. 
Weight was recorded to the nearest 0.1 kg. Calibration of the scales was checked 
daily against an object of known weight. 
The Tuberculin Skin Test: The World Health Organisation standard Tuberculin test 
(Mantoux method) employed a single batch of PPD (purified protein derivative) RT 
23 (Statens Seruminstitut, Copenhagen). Two TU (0.1 ml RT 23) was injected 
intradermally in the ventral aspect of the left forearm, by an experienced nurse, and 
read after a period of 72 hours by the same person. The diameter of the induration 
in millimetres was measured in the transverse aspect of the left forearm with a set of 
callipers calibrated to the nearest 0.5mm. 
The presence or absence of a BCG scar was recorded by the nurse. 
3.4.3. Sputum sampling and processing 
Participants were requested to produce a sputum sample at the health centre where 
the chest radiograph was performed. Sputum sampling was performed in a room 
with laminar airflow and ultraviolet light in order to prevent potential spread of 
organisms. This process was facilitated by a physiotherapist who explained the 
process of expectoration and instructed participants on the active cycle of breathing 
technique. Adults were asked to expectorate into a wide mouthed plastic sputum jar 
(with a secure screw-top lid), close it tightly and place it in a plastic bag provided. At 
the end of each day, all 'cool' boxes were thoroughly cleaned with hycolin. 
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Sputum samples were transported to the laboratory in 'cool' boxes (at ambient 
temperature) and processed using standardised methods within three days. The 
macroscopic appearance of the sputum was recorded. A single smear and a single 
culture were prepared from each sample. Sputum smears were stained with the 
Ziehl Neelsen technique and processed using the standard sodium citrate method. 
Examination for acid fast bacilli (AFB) was performed and the smear was 
considered positive when there was ~1 AFB per 100 power field using the scoring 
system of the International Union Against Tuberculosis and Lung Diseases 
(IUATLD). Each slide was examined for at least 20 minutes. 'Scanty' smears were 
also considered positive. Specimens were cultured on Lowenstein Jensen slants 
and incubated for six weeks at 37 degrees Celsius. 
A second sputum sample was requested from participants who had a single scanty 
smear and/or a positive culture and they were referred to the local clinic for 
treatment. Participants who attempted but were unable to produce a sputum sample 
were considered smear- and culture-negative. 
3.4.4. Chest radiograph 
Participants were requested to present for a chest radiograph at a nearby clinic, and 
transport was provided. In privacy, all females were asked whether they were 
pregnant, and if so, the chest radiograph was performed with a lead abdominal 
shield. Postero-anterior chest radiographs were performed by a trained 
radiographer, using 200 MA radiograph apparatus producing 35cm by 43cm films. 
The candidate or an experienced pulmonologist screened the films for serious 
abnormalities requiring urgent attention and these were referred (by means of a 
home-delivered referral letter and radiograph) to the Respiratory Clinic at the 
Tygerberg Hospital or Groote Schuur Hospital (or to their private doctor if the 
participant wished). There were a total of 40 patients identified for urgent referral 
and they had a wide range of conditions such as tuberculous pleural effusions, 
cardiac failure and lung cancer. 
The radiographs were then formally read by an experienced pulmonologist using a 
new Chest Radiograph Reading System modelled on the International Labour 
Organisation (ILO) Classification Reading Form. This Chest Radiograph Reading 
System was validated and has been reported by den Boon et al (2006).96 A 
subsample was reread by another physician in order to assess agreement and 
evaluate the form as an epidemiological tool. Abnormalities were classified as 
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consistent with TB or not consistent with TB. The former group were subclassified 
into non-mutually exclusive groups called pleural abnormalities, parenchymal 
abnormalities and central structure abnormalities as well as other abnormalities. 
These will not be reported in detail in this mini-dissertation. 
3.4.5. Safety issues: procedure for referral of subjects 
Urgent referral was offered to participants who reported recent haemoptysis or who 
presented with any other obvious medical emergency. They were provided with a 
referral letter to either, the Respiratory Clinic at Tygerberg Hospital, or to the 
Respiratory Clinic at Groote Schuur Hospital for further assessment and 
management. Relevant details of the reason for referral were entered onto the 
standard referral letter and the patients were contacted and encouraged to attend 
the clinic on the same day, or within days. Participants could elect (at their own 
expense) to attend a private doctor, if they preferred. Where necessary, these 
participants (or other acute medical emergencies) were transported in the study 
vehicles to the Medical Emergency/ Casualty Department of Tygerberg Hospital for 
urgent assessment and care. The candidate also made a few home visits when 
interviewers were concerned about the illness of a participant. There were no 
adverse events associated with the conduct of study procedures. 
Non urgent referral was offered to participants who reported untreated respiratory or 
systemic symptoms. The participants were given a referral letter, written by one of 
the coordinating doctors, usually within a week. Their radiographs were viewed by 
one of the doctors on the team. The patients were then contacted and referred to 
the Respiratory Clinic at Tygerberg Hospital and further action was advised 
according to medical indications. 
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3.5. Analysis of data 
3.5.1. Data capture and preparation 
Double data-entry by a data capturer as well as a fax recognition system was used 
to capture and store the data in order to reduce the element of human error. The fax 
recognition system was an original prototype internet based-instrument called 
Prospect, developed by Dr David Carman. This was security controlled by a 
password system. Prospect involved an interface between the fax and computer, 
which allowed for the automatic 'reading' of questionnaire responses. The candidate 
checked the discordant data entries of the fax recognition system and the hand 
capture and corrected discrepancies against the original paper documents, which 
had been scanned into the Prospect system. A Microsoft Access database of the 
adult questionnaire responses was created. The candidate then extracted the data 
from the database by compiling queries in Access and importing the results of these 
queries into a STATA database. 
3.5.2. Statistical analysis 
Analysis was performed using the survey estimation commands in the STATA 9.1® 
statistical package, taking into account both clustering and weighting. Chapter 4 
gives details on the methods used for developing analysis weights. 
3.5.3. Categorisation of variables 
The two binary outcomes analysed were tuberculosis disease and tuberculosis 
infection. These are defined in Chapter One. 
Characterisation of the population in terms of frequency of exposure to the risk 
factor variables described below was performed and is presented in a tabular 
format. 
All risk factors that are significant in the univariate analyses were included unless 
there was a good reason not to include them (e.g. very small numbers with the 
exposure). In the model building process, suspected interactions such as tobacco 
and cannabis smoking were tested for significance by including interaction terms in 
the model. Results from the two multivariable models will be reported in a tabular 
format. 
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The exposure variables were categorised in order to allow for clinical interpretation. 
Where exposure variables were not binary, categorisation of the variables was 
based on previous such categories in the literature (e.g. BMI categories, pack year 
categories for tobacco), natural delineations (e.g. education) or related to clinical 
cutoff points. 
Univariate analysis of risk factors was performed and reported. Multivariate models 
were built based on the results of the univariate analysis and on the a priori 
significance of the variables. 
Tobacco smoking was classified into packyear categories (see Table 12) 
Number of packyears = number of cigarettes per day/20 X number of years 
smoked 
Cannabis smoking 
The categorisation of cannabis exposure has been undertaken in two ways - firstly 
into non-, former and current cannabis smokers, and secondly into cumulative 
exposure categories. The following reasons are given for the latter categorisation. 
Effort was made to consider the cumulative exposure of cannabis. Tashkin et al 
have described a measure known as a joint year.97 A joint year is defined as one 
joint per day for one year. 
The British Thoracic Society published a review stating that the effect of 3-4 
cannabis joints is equivalent to 20 tobacco cigarettes with respect to damage of the 
bronchial mucosa.98 Since tobacco exposure has been categorised into 0-10 pack 
years, 10-20 pack years and >20 pack years - for the purposes of comparison, an 
attempt was made to mirror this categorisation. The equivalent exposure categories 
for cannabis smoking is 0-35 joint years, 35-70 joint years and >70 joint years. 
As some of the cannabis exposure was from pipe smoking, one pipe was 
considered to be equivalent to 2 joints for the purpose of this categorisation. This 
choice is based on estimation and is supported by anecdotal evidence only. 
Occupational exposure was categorised as follows: a) and/orb) 
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a) Have you ever worked in a job that exposed you to silica dust, or involve 
sand blasting, grinding, pottery, work in a quarry/mine or grave stone 
manufacturing? 
b) Have you ever been exposed to other dusts, gases, strong smells, 
chemicals, fumes, at work? 
The categorisation of the other independent variables can be seen in Table 12 ( age, 
sex, BMI, education, income, alcohol and imprisonment). 
3.6. Ethical considerations and informed consent 
The following ethical considerations are in keeping with the Declaration of Helsinki 
(World Medical Association 2000).99 Permission to conduct the study was sought 
and obtained from the Head of the Local Department of Health (Dr Ivan Toms -
Cape Metropolitan Council) and the Provincial Department of Health. The study was 
approved by both the Research Ethics Committee of the Health Sciences (UCT 
REC REF 160/2002) Faculty at the University of Cape Town and the University of 
Stellenbosch. 
An information leaflet accompanied the informed consent document. This described 
the study, clearly indicated that participation was voluntary and assured 
confidentiality. An excerpt from the leaflet is shown below and the interviewers also 
verbally explained both these key issues: 
"All personal information obtained during this study will remain strictly confidential. 
The answers will be transferred to a computer, but your name will not be included, 
and you will be identified by a coded number. No information about individuals will 
be released to any other parties but the research team, without your further consent. 
When the results of research are published (for example, in medical journals), no 
personal details that might identify individuals, or individual households will be 
included." 
The interviewers informed potential participants that taking part in this study did not 
pose any severe risks to them. They were informed that they would be requested to 
complete (with the help of a trained interviewer) a detailed questionnaire about their 
health. The participants were also informed that a TB skin test, called the Tuberculin 
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test, will be performed on all that take part. They were told that in about 70% of 
persons it may form a red, slightly tender lump on the upper arm, at the injection 
site, within a day, which could last for several days, up to two weeks and that 
occasionally, it may blister, or form a shallow sore (ulcer), or cause tender glands 
under the arm. Participants were informed that a health worker would record the 
result of the test after 3 days, when the reaction is strongest, and if necessary, they 
would be provided some cortisone cream to rub on the area to reduce the pain and 
swelling. 
Participants were informed of the following verbally and in the information leaflet: 
"You will be given an appointment and transport to attend the Tygerberg Hospital X-
Ray Department for a chest X-Ray within a few days or weeks of completing the 
questionnaire. At this visit your arm will be examined for a scar from previous TB 
vaccination. Your height and weight will also be recorded. You will then have a chest 
X-Ray. If you are female, in privacy, you will be asked if you are pregnant, and if so, 
your abdomen will be covered by a lead shield, to prevent your baby from being 
exposed to the X-Ray. The chest X-Ray will be reported on by experienced 
specialists. The radiation risk of a standard chest X-Ray is very small. You will be 
asked to try and cough up some phlegm for examination for TB organisms." 
The interviewers explained this information to potential participants, who were given 
the opportunity to ask questions. No study procedures were undertaken unless the 
participants indicated that their questions had been answered to their satisfaction. 
Participants were asked to sign a consent form after they had read and understood 
the information leaflet. They were given an original copy of both the leaflet and the 
consent form to keep. 
Written signed informed consent was requested and obtained for all participants. 
Minors under the age of 18 years provided verbal assent and were required to 
obtain written informed consent from a parent or legal guardian, without which 
participation was not possible. All home interviews were conducted by trained 
interviewers and height, weight and tuberculin skin testing was conducted by 
registered nursing staff. Chest radiographs and collection of sputum samples were 
performed by qualified radiographers and a physiotherapist respectively. 
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CHAPTER 4: RESULTS 
4.1. Response rate 
The response rates for the different components and procedures in the project are 
presented in the following flow chart: 
3971 persons ~15 years eligible for inclusion according to the sampling method 
D 
3483 consented and completed questionnaire (88%) 
D 
2834 persons had a TST (81% of consenters) 
D 
2608 had a chest radiograph and attempted to produce sputum (75% of consenters) 
D 
1170 provided a sputum sample (45% of those that attempted, 34% of consenters) 
Figure 3: Response rates for the Lung Health Survey 
At the enumeration visit, 625 out of the 839 addresses (74%) consented to 
participation via the head of the household/s. Of the 214 non consenting addresses, 
212 were replaced, two could not be replaced and four addresses were found not to 
exist. Demographic characteristics (age and sex) of the occupants of 81 of the non-
participating and all the participating addresses were collected. A comparison of the 
age and sex characteristics of the replaced addresses and the non-consenting 
addresses showed no significant difference with respect to age (t test = 0.33; p = 
0.74) or sex (OR= 1.0; Cl: 0.82 - 1.23) of the occupants. 14 
The final sample consisted of 833 addresses with 3971 eligible persons aged ~15 
years, of which 3512 gave consent and participated in the questionnaire. Age and/or 
sex data was missing or incorrect for 29 individuals (therefore not analysable on this 
basis) leaving 3483 (88%) with sufficient data for analysis. Of these 75% (2608) had 
a chest radiograph and attempted to provide a sputum sample and 45% ( 1170) 
produced a sputum sample (Figure 3). 
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4.2. Development of analysis weight factors 
In this survey, the primary sampling unit (PSU) was an address and the analysis 
takes this clustering into account. The census and sample response rate proportion 
was calculated for the consenting original and consenting replacement addresses. A 
response rate for two age and gender categories was calculated ( 15-44 years and 
>45 years) and the realisation proportion was calculated for them (unequal response 
rates in these four sex and age groups) 
The address weight which is the selection probability for a random address was 0.15 
(839/5592) and therefore the number of persons represented by each of these 
addresses is the inverse of this i.e. 6.67 persons. 
The response rate for the original addresses was 0.898 (3824/4258), and the 
response rate for the replacement addresses was 0.859 ( 1272/1481 ). The response 
rate for men >45 years was the lowest. Separate weights were calculated for the 
original consenting and the replacement addresses. 
The realisation weight extrapolates the individuals in the sample in terms of how 
many persons they represent of the population. For persons in the original 
addresses this weight was 1.114 ( 1 /0.898); and for persons from the replacement 
addresses it was 1.164 (1/0.859). By multiplying the address weight and the 
realisation weight, one is able to identify the adjusted number of persons 
represented by the individual. Persons living at the original addresses represent on 
average 7.43 persons in the population and persons at the replacement addresses 
represent 7.76. 
The final sampling weight for each individual was a product of the inverse of the first 
stage sampling probability of an address (original vs. replacement PSUs) and the 
inverse of the response rate of that individual's specific age and gender subgroup. 
These weights were linked to each unique identifier in the database. The weights 
were used by setting the proportion weight as these individual weights and 
clustering was accounted for by setting the PSU as an address identifier, using the 
"survey analysis" commands in STATA 9.1®. 
35 
4.3. Outcomes 
4.3.1. Past/current TB disease 
The prevalence of past tuberculosis was based on the question; "Has a 
doctor/health worker ever told you that you have TB (see question 17, Appendix 2) 




All n (%) 
3146 (90.3) 




Women n (%) p* 
1831 (92.1) <0.001 
159(8.0) 
* Pearson's chi-squared test reporting the significance of the difference between men and women. 
1. The prevalence of past TB was 9.7% (n=337). See Table 4. 
2. The prevalence of current bacterially positive TB was 1 % (26/2608) (see 
Chapter 1 for definition). A total of 2608 persons attempted to provide a sputum 
sample. Persons who attempted but failed to produce a sputum sample were 
assumed to be smear and culture negative. 
Therefore the prevalence of past/current TB disease was 10.4%. (first outcome 
to be analysed). The age-related prevalence of TB disease is described in Table 
13, and shows a steady increase with age and also a significantly greater 
prevalence in men. (12. 7% vs. 8.5%; p <0.001) 
4.3.2. TB infection 
The prevalence of TB infection was 76% (n= 2194). Figure 4 shows the distribution 
of TST size. The age related prevalence TST positivity is shown in Table 14. It is 
high at all ages and decreases slightly with age, with the persons >65 years 
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Figure 4: Histogram of the distribution of tuberculin skin test size in 
persons ~5 years(% population vs. TST in centimeters) 
4.4. Exposure 
Table 5: Prevalence of cannabis smoking (n=3483) 
All: n (%) Men: n (%) Women: n (%) 
(n=3483} (n=1493} (n=1990} 
Never smokers 3088 (88.7) 1149 (77.0) 1939 (97.5) 
Ex smokers 173 (5.0) 146 (9.8) 27(1.4) 
Current 1 - 2 joints per day 89 (2.6) 77 (5.2) 12 (0.6) 
Current ;:: 3 joints per day 57 (1.6) 51 (3.4) 6 (0.3) 




* Pearson's chi-squared test reporting the significance of the difference between men and women. 
Twelve percent ( 411) admitted to smoking substances other than tobacco. Most 
were cannabis smokers (395). Twenty three percent of men and 2.6 percent of 
women had ever smoked cannabis. The majority of cannabis smokers were male 
and just under half of male smokers (9.8% of the male population, see Table 5) 
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were ex-smokers at the time of the survey. A significant proportion of men were 
current smokers (222 participants - 13.2% ). 
"Pipe" smoking (a pipe usually being a makeshift 'pipe' - see Figure 1) was 
practised by 118 persons and 76 of these (2.2% of the total population or 34.2% of 
cannabis users) smoked cannabis pipes exclusively. The remainder (42 persons) 
smoked both joints and pipes. 
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Figure 5: Prevalence of current and previous cannabis smoking in men and 
women 
Figure 5 presents the percentages of male and female cannabis smokers and ex-
smokers in different decades of age, and shows that relatively few persons began 
smoking after the third decade. The highest prevalence of current cannabis smoking 
was in men aged 35 - 44 ( 16. 7% ), and amongst women it was in the 15 - 24 age 
group (2.0%). The prevalence drops off by almost a half by the sixth decade and few 
persons older than 55 years smoke cannabis. 
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Table 6: Lifetime exposure to cannabis smoking (n=395) 
All: median Men: median Women: median 
(25th - 75th centile) (25th - 75thcentile) (25th - 75th centile) 
(n=395} (n=345} (n=51} 
Age started smoking 18 (16 - 20) 17(16-20) 18 (16 - 23) 
(range= 6-60 years of age) 
Age stopped smoking 25 (19 - 33) 25 (19- 35) 24 (19 - 29) 
(in ex smokers*; n=173) 
Number of years smoked 9 (3.2 - 20.9) 10 (3.8 - 21.9) 4.3(1.8-11.1) 
Joint years** 30.0 (10.4 - 88.0) 34 (11.6 - 99.2) 11.7 (4.0 - 30.6) 
* An ex smoker is defined as a person who stopped smoking more than one month before the date of 
interview. 
** 1 joint year = an average of 1 joint per day for 1 year
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The median age of commencing cannabis smoking was 18. A quarter of smokers 
had already started smoking by age 16, half by age 18 and three quarters by age 
20. Those that stopped did so in their late 20's or early 30's. (Table 6) 
Men smoked longer than women (median of 10 vs. 4.3 years).Overall the median 
time was nine years in a relatively young population (70% of the population was 
under the age of 45 years). A median number of joint years of 30 was high and the 
higher prevalence of cannabis smoking in men accounted for higher cumulative 
exposure 
The percentage of ever cannabis smokers with past or current tuberculosis was 
significantly higher than that for non-cannabis smokers. Table 7 shows that twenty 
one percent (83/395) of ever cannabis smokers had past/current TB and 8.9% of 
non cannabis smokers (273/3079) had past TB (p<0.001 ). 
Of all persons with current/past TB almost a quarter (23.3%) had smoked cannabis 
whereas among those with no current/past TB, only 10% had smoked cannabis 
(p<0.001) 
Categorisation of cannabis smoking and other variables are discussed in Chapter 3. 
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Table 7: Relationship between cannabis smoking (ever) and. past or 
current TB disease 
Percentages are presented by row (in bold print) and for each column (in italics) 
No Cannabis Cannabis Total 
smoking n (%) smoking n (%) n (%) 
No TB disease 2806 312 3118 
90.0% 10.0% 100% 
91.1% 79.0% 89.8% 
TB disease 273 83.0 356 
76.7% 23.3% 100% 
8.9% 21.0% 10.3% 
Total 3079 395 3474 
88.6% 11.4% 100% 
100% 100%% 100% 
Table 8: Distribution of TB disease in cannabis smokers by joint years 
Past/current Joint year categories n (%) 
TB 0 0-35 35-70 >70 Total 
No 41 (89.1) 151 (86.3) 42 (77.8) 56 (60.2) 290 (78.8) 
Yes 5 (10.9) 24 (13.7) 12 (22.2) 37 (40.0) 78 (21.2) 
Total 46 (100) 175(100) 54 (100) 93(100) 368(100)* 
*27 persons had insufficient information for the accurate calculation of joint years 
Increasing joint years was associated with an increasing prevalence of past/current 
TB disease. Forty percent of cannabis smokers with a >70 joint year history had 
past/current TB disease. (p<0.001) 
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Table 9: Relationship between cannabis smoking and incarceration 
(imprisonment). 
Percentages are presented by row (in bold print) and for each column (in italics) 
No incarceration n Incarceration n Total 
(%) (%) n (%) 
Cannabis(never) 2936 121 3057 
96.0% 4.0% 100% 
92.5% 44.3% 88.7% 
Cannabis (ever) 238 152 390 
61.0% 40.0% 100% 
7.5% 55.7% 11.3% 
Total 3174 273 3447 
92.1% 7.9% 100% 
100% 100% 100% 
*each percentage is rounded to the first decimal place 
Forty percent of cannabis smokers had a history of incarceration (Table 9). 
Approximately 56 percent of persons with a history of incarceration had a history of 
cannabis exposure. Of all persons with a history of incarceration and cannabis 
smoking, 25% (38/152) had past TB. Of all those cannabis smokers with no history 
of incarceration 15.8% (42/266) had past TB. 
Table 10: Relationship between cannabis smoking and tobacco smoking 
Percentages are presented by row (in bold print) and for each column (in italics) 
Tobacco (never) n Tobacco ( ever) n Total 
(%) (%) n (%) 
Cannabis(never) 1440 1637 3057 
46.8% 53.2% 100% 
97.9% 81.9% 88.7% 
Cannabis (ever) 31 363 390 
7.9% 92.1 100% 
2.1% 18.2 11.3 
Total 1471 2000 3471 
42.4% 57.6% 100% 
100% 100% 100% 
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Of all persons who had ever smoked cannabis, 92.1 percent also ever smoked 
tobacco (Table 10). There were thus very few exclusive cannabis smokers. Of all 
those who had ever smoked tobacco, 18.2% had ever smoked cannabis. Of all 
current tobacco smokers, 11.5% were current cannabis smokers (not shown). 
Table 11: Relationship between cannabis smoking and evidence of TB 
abnormality on chest radiograph 
Percentages are presented by row (in bold print) and for each column (in italics) 
No TB abnormality TB abnormality on Total 
on radiograph n (%) radiograph n (%) n (%) 
Cannabis( never) 2045 277 2322 
88.1% 11.9% 100% 
90.3% 82.2% 89.3% 
Cannabis (ever) 219 60 279 
78.5% 21.5% 100% 
9.7% 17.8% 10.7% 
Total 2264 337 2601 
87.0% 13.0% 100% 
100% 100% 100% 
Overall, 13% (337 out of 2608 persons) had an abnormality in keeping with TB on 
the chest radiograph (Table 11 ), and 51.5% of persons with past TB had a TB 
abnormality on CXR (not shown) Of all cannabis smokers, 21.5% had a TB 
abnormality and 11.9% of non cannabis smokers had a TB abnormality. 
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Table 12: Sex distribution of other potential risk factors for tuberculosis 
(n=3483) 
Characteristics All n (%) 
Menn(%) Women n (%) p* n= 
Income**: >R2000/month 631 (18.4) 388 (26.0) 255 (12.8) <0.001 
R1 OOO-R2000/month 623 (18.2) 290(19.4) 344 (17.3) 
<R1000/month 2168 (63.4) 815 (54.6) 1391 (69.9) 
Education: (years): >12 years 701 (20.1) 340 (22.8) 362 (18.2) <0.001 
8-12 years 1842 (52.9) 797 (53.4) 1046 (52.6) 
1-7 years 832 (23.9) 315(21.1) 517 (26.0) 
None 106 (3.1) 41 (2.8) 65 (3.3) 
Age: (years): 15-24 969 (27.8) 429 (28.7) 540 (27.1) <0.001 
25-34 742 (21.3) 321 (21.5) 421 (21.2) 
35-44 732 (21.0) 346 (23.2) 386 (19.4) 
45-54 471 (13.5) 191 (12.8) 280 (14.1) 
55-64 331 (9.5) 126(8.4) 205 (10.3) 
>65 237 (6.8) 79 (5.3) 158(7.9) 
Cannabis: 0 joint years 3118 (90.6) 1178(80.3) 1940(98.3) <0.001 
0-35 joint years 175(5.1) 149(10.2) 26 (1.3) 
35-70 joint years 55(1.6) 50(3.4) 5 (0.3) 
> 70 joint years 93(2.7) 91 (6.2) 2 (0.1) 
Tobacco: 0 pack years 1570 (45.1) 527(35.3) 1043 (52.4) <0.001 
0-1 0 pack years 1335 (38.3) 626 (41.9) 709 (35.6) 
10-20 pack years 305 (8.8) 172 (11.5) 133(6.7) 
>20 pack years 273 (7.8) 168 (11.3) 105 (5.3) 
Incarceration: No 318 (92.1) 1234 (83.3) 1946 (9807) <0.001 
Yes 274 (7.9) 248 (16.7) 26 (1.3) 
BMI: normal weight 18.5-25 1233 (43.8) 796 (53.3) 742 (37.3) <0.001 
Overweight BMI >25 & <30 653 (23.2) 308 (20.6) 498 (25.0) 
Obese BMl~30 617 (21.9) 161 (10.8) 591 (29.7) 
Underweight BMI <18.5 309 (11.0) 228 (15.3) 159 (8.0) 
Occupational exposure: Never 2569 (73.8) 939 (62.9) 1630 (81.9) <0.001 
Ever 914 (26.2) 554 (37.1) 360 (18.1) 
Domestic fuels: Non- smoky 3415(98.1) 1468 (98.4) 1947 (97.8) 0.1705 
Smoky 67 (1.9) 24 (1.6) 43 (2.2) 
Alcohol: None 2284 (65.6) 759(50.9) 1525 (76.6) <0.001 
1-2 days/week 762 (21.9) 432 (30.0) 330 (16.6) 
3-4 days/week 307 (8.8) 205 (13.7) 102 (5.1) 
2:5da~s ~er week 129(3.7) 96 (6.4) 33 (1.7) 
* Chi squared test for the difference between men and women; **R1000month-US$ 98.77; ***small 
numbers in this group 
Table 12 confirms significant differences between the sexes in respect of several 
factors ( other than cannabis use) that may be associated with increased risk of 
tuberculous infection and disease. These include age, education, income, BMI, 
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tobacco smoking, imprisonment, and alcohol use and occupational exposure. There 
was little current exposure to smoky fuels in this community as it is an urban area 
that is mostly electrified, and no data regarding past exposure was collected. 
Most of the population earned less than R1000 per month (63.4%), and almost 70% 
of women were in this extremely low income category. Just over half the population 
(52.9%) had a high school education. There were low numbers of men in the >65 
age group (79). Almost twice the percentage of men than women reported 
occupational dust exposure (37 .1 % vs. 18.1 % ). 
There was a high level of tobacco exposure and the majority of men and women 
had a O - 10 packyear history (38.3%) and a higher percentage of men had greater 
cumulative exposure. Similarly, the majority of male cannabis smokers fell into the 
0-35 joint year category (10.2%), but 6.2% had a >70 joint year exposure. 
Twenty five percent of women were overweight and a further 29. 7% were obese. 
Being underweight was more common in men (15.3%) and a history of incarceration 
was reported by 16.7% of men in this community. 
4.4. Risk factor analysis 
4.4.1. TB disease 
Univariate analysis of risk factors associated with past or current TB was 
performed. All the a priori risk factors were significantly associated with TB disease. 
The strongest association was with cannabis smoking of >70 joint-years (OR: 6.8; 
Cl: 4.4 - 10.6) and 35 - 70 joint years (OR 2.9; Cl: 1.5 - 5. 7) and O - 35 joint years 
(OR 1.6; Cl: 1.0 - 2.6), showing a dose dependent association, which was retained 
in the multivariate analysis, which adjusted for nine other potential risk factors. 
Cannabis smoking of >70 joint-years was associated with TB disease (OR 3.2; Cl: 
1.8 - 5.6). 
Tobacco smoking of >20 pack years (OR 3.3; Cl: 2.3 - 4.7) and 10-20 packyears 
(OR 1.8; Cl: 1.2 - 4.7) and 0-10 packyears (OR 1.5; Cl: 1.2-2.0) also showed a 
dose dependent association. Income <R1000 per month, lower levels of formal 
education, increasing age, imprisonment, male gender, alcohol use and being 
44 
underweight were all associated with TB disease (see Table 13). There appeared to 
be a protective effect associated with being overweight or obese. 
A multicollinearity matrix was created adjusting for all dependent variables and none 
of the variables had a coefficient of >0.8, suggesting that there was no need to 
remove any variables on the basis of multicollinearity. The adjusted Pearson's 
correlation coefficient for joint years vs. packyears was 0.1972. 
In the multivariate model of risk factors for past or current TB disease, several risk 
factors were no longer significant. Those that remained significant were, cannabis 
smoking of >70 joint years (OR 3.2; Cl: 1.8 - 5.6), tobacco smoking of >20 
packyears (OR 1.7; Cl: 1.1- 2.6), increasing age (see Table 13) and being 
underweight (OR 1.8; Cl: 1.2 - 2.6). 
Obesity (OR 0.4; Cl: 0.2 - 0.6) and being overweight (OR 0.5; Cl: 0.3 - 0.7) retained 
their apparent protective effect. There were two borderline associations viz. low 
income and occupational exposure. 
Since the models for tobacco and cannabis exposure presented in this chapter were 
selected in order to examine potential dose-dependent effects of tobacco and 
cannabis smoking on TB disease they were included as cumulative exposures. 
However, this categorisation is not well suited for an assessment of interactions with 
other categorised risk factors as the cell sizes become too small. 
Therefore, further analyses expressing cannabis exposure as non-, ex- and 
current cannabis smoking were performed. In this analysis (presented in 
Appendix 3) a significant association of ex- and current cannabis smoking with 
tuberculosis disease was observed. However, there was no significant interaction 
between cannabis smoking and tobacco smoking in this analysis (p =0.27). 
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Table 13: Logistic regression showing the association of current/past 
tuberculosis disease with risk factors (n = 2716) 
N with %with Unadjusted Adjusted OR 
past/current past/current OR (95%CI) (95%CI) 
tuberculosis tuberculosis 
I total Nin 
category 
Income**: >R2000/month 42/631 6.7% 1.0 1.0 
R1 OOO-R2000/month 49/623 7.9% 1.2 (0.9 - 1.8) 1.0 (0.6 - 1.6) 
<R1000/month 263/2168 12.1% 1.9 (1.4- 2.8) 1.6 (1.0 - 2.6) 
Education: >12 years 44/701 6.3% 1.0 1.0 
8-12 years 171/1842 9.3% 1.5 (1.1 - 2.1) 1.4 (0.9 - 2.0) 
1-7 years 132/832 15.9% 2.8 (2.0 - 4.0) 1. 5 ( 1. 0 - 2.4) 
None 12/106 11.3% 1.9 (1.0 - 3.7) 0.8 (0.3 - 2.0) 
Age: 15-24 64/969 6.6% 1.0 1.0 
25-34 71/742 9.6% 1.5(1.0-2.1) 1.9 (1.2 - 3.0) 
35-44 92/732 12.6% 2.0 (1.5 - 2.8) 2.4 (1.5 - 3.9) 
45-54 62/471 13.2% 2.1 (1.5-3.1) 2.4 (1.4- 4.1) 
55-64 50/331 15.1% 2.5 (1.7 - 3.7) 3.0 (1.8 - 5.0) 
>65 20/237 8.4% 1.3 (0.8 - 2.2) 1.6 (0.8 - 3.1) 
Tobacco: 0 pack years 117/1570 7.5% 1.0 1.0 
0-10 pack years 147/1335 11.0% 1.5 (1.2 - 2.0) 1.1 (0.8-1.5) 
10-20 pack years 38/305 12.5% 1.8 (1.2 - 2.6) 0.8 (0.5 -1.4) 
>20 pack years 57/273 20.9% 3.3 (2.3 - 4. 7) 1.7 (1.1 - 2.6) 
Cannabis: 0 joint years 275/3118 8.8% 1.0 1.0 
0-35 joint year 24/175 13.7% 1.6 (1.0 - 2.6) 1.2 (0.7 - 2.2) 
35-70 joint years 12/55 21.8% 2.9 (1.5- 5.7) 1.3 (0.6 - 2.9) 
> 70 joint years 37/93 39.8% 6.8 (4.4- 3.2 (1.8 - 5.6) 
10.6) 
Occupational exposures: 
Never exposed 236/2569 9.2% 1.0 1.0 
Ever exposed 123/914 13.5% 1.5 (1.2 -1.9) 1.3 (1.0 - 1.8) 
BMI: normal weight 18.5-25 157/1233 12.7% 1.0 1.0 
Overweight BMI >25 & <30 42/653 6.4% 0.5 (0.3 - 0.7) 0.5 (0.3 - 0.7) 
Obese BMl~30 34/617 5.5% 0.4 (0.3 - 0.6) 0.4 (0.2 - 0.6) 
Underweight BMI <18.5 68/309 22.0% 1.9 (1.4- 2.7) 1.8 (1.2 - 2.6) 
Gender: Female 170/1990 8.5% 1.0 1.0 
Male 189/1493 12.7% 1.5(1.2-1.9) 1.0 (0. 7 - 1.3) 
Alcohol None 202/2284 8.8% 1.0 1.0 
1-2 days/week 82/762 10.8% 1.2 (0.9 - 1.6) 1.1 (0.8 - 1.5) 
3-4 days/week 48/307 15.6% 1.9 (1.4- 2.7) 1.3 (0.8 - 2.0) 
2:5 days/week 27/129 20.9% 2.7 (1.7 - 4.4) 1.0 (0.5 - 1.8) 
Incarceration No 289/3180 9.1% 1.0 1.0 
Yes 67/274 24.5% 3.2 (2.4 - 4.4) 1.2(0.8-1.8) 
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Table 14: Analysis of risk factors for TB infection using survey 














Tobacco: 0 pack years 
0 -10 pack year 
10-20 pack years 
>20 pack years 
Cannabis: 0 joint years 
0-35 joint year 
35-70 joint years 




BMI: normal weight 18.5-25 
Overweight BMI >25 & <30 
Obese BMI >30 






2:5 days per week 
Incarceration: No 
Yes 
4.4.2. TB infection 
N with TB infection 












































































0.9 (0.7 - 1.3) 
0.6 (0.4 - 0.8) 
1.0 
0.8 (0.6 - 1.0) 
1.1(0.8-1.4) 
0.4 (0.2 - 0.6) 
1.0 
4.3 (3.2 - 5.8) 
3.2 (2.4 - 4.2) 
2.4 (1.8 - 3.3) 
1.5 (1.1 - 2.0) 
0.6 (0.4 - 0.8) 
1.0 
1.7(1.4-2.2) 
3.3 (2.1 - 5.0) 
1.8 (1.3 - 2.6) 
1.0 
1.9(1.2-3.1) 
2.8 (1.0 - 7.6) 
4.0 (1.7 - 9.9) 
1.0 
1.6 (1.3 - 2.0) 
1.0 
1.1 (0.9 - 1.5) 
0.9(0.7-1.1) 






1.3 (0.7 - 2.2) 
1.0 





1.0 (0.7 - 1.3) 
1.0 
0.9 (0.7 - 1.2) 
1.2 (0.9-1.7) 
0.7 (0.4 - 1.2) 
1.0 
4.1 (2.9 - 5.7) 
2.6 (1.9 - 3.6) 
2.0 (1.4 - 2.9) 
1.4 (0.9 - 2.0) 
0.5 (0.3 - 0.8) 
1.0 
1.4 (1.1 -1.8) 
2.2 (1.4 - 3.5) 
1.5 (1.0 - 2.3) 
1.0 
1.2 (0. 7 - 2.2) 
1.0 (0.3 - 2.7) 
1.4 (0.6 - 3.6) 
1.0 




1.2 (0.9 - 1.6) 
0.9 (0.6 - 1.4) 
0.7 (0.4 - 1.2) 
1.0 
3.6 (1.8 - 7.1) 
A similar process was followed for building the model that examines TB infection. All 
exposures examined, apart from BMI were significant in the univariate analysis, and 
were thus included in the multivariate analysis. There appeared to be no association 
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between cannabis smoking Uoint-year categories) and tuberculosis infection (see 
Table 14). 
However, an association of tuberculosis infection and former cannabis smoking (OR 
2.0; Cl: 1.1- 3.6) was seen in a model categorising cannabis smoking (and tobacco 
smoking) into non, ex and current smoking, without adjusting for incarceration (see 
Appendix 3). Incarceration appeared to confound the relationship between former 
cannabis smoking and tuberculosis infection. However, an interaction term included 
to test the overall significance of the cannabis/incarceration relationship, proved to 
be non-significant at the 5% level (p=0.1302). However, the interaction between 
former cannabis smoking and incarceration was significant (p= 0.046). 
4.4.3. Population attributable fractions (PAF) 
Population attributable fractions were calculated for the modifiable risk factors of 
interest. Heavy cannabis smoking had a PAF of 5.6%. Levin's formula was used as 
follows: 
PAF = prevalence of exposure (OR-1)/1 + prevalence of exposure (OR-1) 
Table 15: Population attributable fractions for tuberculosis disease 
Percentage Prevalence Odds Population 
exposed to Ratio (multivariate Attributable 
risk factor model) Fraction (%) 
Cannabis smoking > 70 joint 2.7 3.2 5.6 
years 
Tobacco smoking >20 pack years 7.8 1.7 5.2 
Underweight (BMI <18.5) 11 1.8 8.1 
The population attributable fraction for cannabis smoking of> 70 joint years was 
5.6%. 
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Table 16: Population attributable fractions for tuberculosis infection 
Percentage Prevalence Odds Population 
exposed to Ratio (multivariate Attributable 
risk factor model) Fraction (%) 
Incarceration 7.9 3.6 17 
Tobacco smoking O - 10pack 
years 
38.3 1.4 13.3 
Tobacco smoking 10-20 pack 8.8 2.2 9.6 
years 
Tobacco smoking >20 pack years 7.8 1.5 3.8 
An assessment of reliability and repeatability was performed by administering the 
questionnaire on a second occasion days or weeks after the first administration, and 
by a different interviewer. This was performed in a sample of 5% of respondents. 
Selected questions were analysed for percentage agreement between the first and 
second interview, and this was found to be acceptable (kappa= 0.7) 
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CHAPTER 5: DISCUSSION 
5.1. Significance of the research question 
This study aims to contribute to the field of public health by highlighting cannabis as 
a potential risk factor for tuberculosis and informing public health policy in terms of 
the need to address risk factors such as tobacco and cannabis smoking as part of 
the strategic prevention and management of the tuberculosis epidemic. 
Tobacco and cannabis smoking are modifiable risk factors. The strengthening of 
smoking cessation messages in primary health care is currently underway as part of 
the Practical Approach to Lung Health in South Africa (PALSA Plus) in conjunction 
with the South African Department of Health. From a health services and health 
promotion perspective, understanding the association between smoking of both 
tobacco and cannabis and TB can add impetus to smoking cessation interventions, 
and can be used in educational public awareness efforts.25 
There appears to be a need to include cannabis in anti-smoking messages and 
interventions, particularly in the high risk communities and to include this in the 
tuberculosis control programme. The results of this study will be communicated to 
the Department of Health TB Directorate (national), provincial and local health 
services, and used to motivate for a smoking cessation service at TB Clinics in the 
Western Cape, and countrywide. 
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5.2. Discussion of methodology 
5.2.1. Bias 
Selection bias 
The study design was susceptible to a selection bias in that sampling of clusters 
(addresses) as the primary sampling unit could result in a biased estimate of the 
outcomes (TB) arising from common exposure of household contacts to infected 
individuals in households. This effect would have been reduced by the large sample 
size; the 15% sample of addresses is considered adequate for this purpose. 
Moreover, as TB is common throughout the study area, and did not appear to be 
concentrated in any section of the suburbs sampled (See Figure 1 ), this influence is 
likely to have been small, if not insignificant. In addition, the effect of clustering has 
been corrected for by appropriately weighting the observations (see Chapter 4). 
The resampling and replacement procedure is another potential cause of selection 
bias, but its significance is not possible to estimate. On the one hand, persons at 
addresses with recent or current tuberculous disease might have felt less inclined to 
participate owing to fear of stigmatisation. In this scenario, the replacement 
procedure would have introduced underestimation of the outcome. Conversely, 
some persons at the sampled addresses would have been more likely to consent if 
they had experienced TB disease. This would have led to overestimation of the 
outcome. 
Information bias (outcomes and exposure) 
In any questionnaire based study some amount of recall bias is inevitable. For 
example, exposures such as to occupational agents may be overreported and 
exposures such as cannabis or cigarette smoking may be underreported. The 
impact of these sources of potential bias cannot be estimated but their direction can 
be suggested. 
Firstly, the definition and recall of the outcome of tuberculosis disease is subject to 
some limitations. In this study, a history of tuberculosis disease was reported by 
subjects and not confirmed by the investigators. This is somewhat mitigated by the 
fact that the information was interrogated further through questions on the number of 
episodes and the dates of each treatment course. A bias in the assessment of the 
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outcome of tuberculosis could be caused by stigmatisation of the diagnosis in the 
community, potentially resulting in underreporting. However, TB is not an acute 
disease, and its symptoms are protracted. Thus a diagnosis of tuberculosis and 
treatment for 6 months is likely to be remembered. Another factor that could have 
counteracted this recall bias is the higher levels of awareness of tuberculosis in this 
community owing to previous TB research having being conducted in these suburbs 
for the last 15 years. 
Secondly, self reporting of the main exposure of cannabis smoking is subject to 
recall/reporting bias owing to the illegal nature of the activity and the likely social 
stigmatisation associated with its use. This would have served to underestimate 
exposure (joint years), and reduce the strength of association. 101 This may have 
contributed to or accounted for the lack of evidence of a dose-related effect of 
cannabis smoking with tuberculosis infection in this study, whereas cruder variables 
such as non, ex and current smoking showed an association with ex- cannabis 
smoking in the adjusted analysis. 
This bias may differ between sexes, women potentially being more reluctant to 
admit cannabis use because of the lower background use among women; and it 
being less socially acceptable for them compared to men in this community. 
Interviewers were blinded to the hypothesis and thus the potential of observer bias 
was reduced. In addition, interviewers were well trained in the standardised method 
of questionnaire administration which involved not expressing any reaction to 
participant's answers, so as not to influence their answers 
It is acknowledged that risk factor analysis in a population-based study cannot 
ascribe causality but merely association, and even then the direction of effect is in 
some cases difficult to ascertain. It also does not address potentially relevant details 
regarding the type of cannabis smoked and nor does it provide an accurate estimate 
of the quantity smoked. However, most studies on tobacco smoking also suffer from 
similar limitations and rely heavily on self reporting. 
In spite of these limitations and potential sources of bias, principally resulting in 
underreporting, the current study, being the first population-based study to address 
the association between cannabis smoking and tuberculosis, provides some 
important results that may serve as a guide to further research on this topic. 
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5.2.2. Misclassification 
The outcome of past tuberculosis was not based on the result of an objective test 
and is therefore prone to misclassification. In the case of current tuberculosis 
disease and tuberculosis infection, the chances of misclassification are smaller as 
they were based on standardised quality controlled procedures (sputum microscopy 
and culture). 
Misclassification of smoking behaviour is also a factor to consider. There are 
multiple ways of classifying smoking patterns, ranging from current and ever 
smoking to more detailed measures including duration and intensity/amount such as 
packyears. This misclassification is likely to be non-differential and would have had 
the effect of reducing risk estimates towards the null.25 
Exposure to cannabis smoking was obtained from questionnaires alone and was not 
possible to verify through objective measures in this sort of survey. Tests for current 
smoking through measurement of urinary tetrahydrocannabinol (THC) would have 
been useful. This was not logistically feasible in this study, and could be considered 
in future studies. Nevertheless, the face validity of the data was plausible. 
5.3. Discussion of results 
5.3.1. Relationship of cannabis smoking and tuberculosis disease 
Both the prevalence and cumulative exposure of cannabis smoking is high in men 
(23% ever smokers and 13% current smokers with a median of 34 joint years) and, 
surprisingly, was found to be practiced in similar proportions of men in all age 
deciles ( 10 - 17 percent). This confirmed that regular cannabis use is not a passing 
fad of youth, but becomes a life-long habit in this community. In this respect, its use 
in this community is different to that described in developed countries, where it is 
used mainly by adolescents and young adults. 102 Although the reasons for this are 
open to speculation, it might reflect the social use of cannabis smoking as an 
'escape' from the harsh realities of poverty and unemployment. On the other hand, 
its role in perpetuating the 'poverty cycle' through interfering with the regular 
cannabis smoker's ability to obtain and retain regular employment is also important 
to consider (amotivational syndrome). Another influence is the potential impact of 
membership of 'gangs' or informal groupings of cannabis smokers in a sub-culture 
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within the communities studied. Further research using qualitative methods are 
required to examine the social behaviour and structures that facilitate cannabis use, 
and the structure and economics of the supply chain that feeds the habit in this 
community. 
Tobacco and cannabis smoking are clearly linked phenomena. The median age of 
onset of cannabis smoking is only one year later than that of cigarette smoking. This 
has implications for public health interventions suggesting that both need to be 
addressed simultaneously in the young. Unlike tobacco smoking, cannabis smoking 
appears to be uncommon amongst women. However, the illegal status of the drug 
poses a problem for the collection of accurate data, and can give rise to distorted 
prevalence figures (see Information Bias 5.2.1.). 
Rigorous attention was paid to the inclusiveness of the model in order to minimise 
the possibility of chance associations. All a priori risk factors for tuberculosis were 
included in the multivariate model, if they were significant in the univariate analyses. 
Of particular importance were incarceration and alcohol use, both of which have not 
been uniformly addressed as confounders in the majority of studies examining the 
relationship between tobacco smoking and tuberculosis. Evidence for this can be 
seen in Tables 2 and 3 in Chapter 2 which list the adjusted variables in each study. 
Confounding 
In the model building process, the addition of incarceration into the model produced 
the largest effect in terms of reduction in the strength of association of tuberculosis 
with cannabis smoking. Sex and tobacco smoking each caused smaller reductions 
of the association of cannabis with TB disease. The other variables - BMI, 
education, 'wealth', alcohol, occupational exposure and age each had much smaller 
effects on the cannabis association. Unmeasured variables such as methaqualone 
use may also have contributed to confounding. 
Co-linearity with tobacco smoking was considered for the multiple logistic regression 
model in which they were both included. Since 92% of cannabis smokers also 
smoked tobacco, delineating the separate effects may be difficult, and may limit the 
interpretation of the results. This was addressed in part by multivariate logistic 
regression adjusting for both variables as it helps to separate the effects of the 
different variables on the outcome. Tests for co-linearity between cannabis and 
tobacco smoking were not significant most probably due to the fact that only 18% of 
54 
tobacco smokers smoked cannabis (Pearson correlation coefficient(r) = 0.2). The 
correlation between the two variables is weak and co-linearity should not be a 
problem in this model. This was confirmed since the estimated risk measures for 
cannabis smoking and tobacco smoking were coherent. In the case of models with 
significant co-linearity the overall model explains a significant component of the 
variation of the outcome variable but the co-linear factors are not significant or have 
incoherent results in comparison to a model with one of the risk factors present. 
Also, finding associations between both tobacco smoking and cannabis smoking 
and tuberculosis is biologically plausible in view of the many similarities between 
both types of smoke, at least with respect to their effects on the lungs. Lastly, 
despite adjusting for many different known variables, the possibility of residual 
confounding from unknown/unmeasured variables may exist. 
A surprising finding however, was the apparent greater strength of the association of 
TB disease with cannabis than with tobacco smoking. Apart from biological or 
mechanistic differences, this might also be attributable to differences in the smoking 
practices and the social context of cannabis smoking, compared to tobacco smoking 
that might increase opportunities for transmission, and person to person spread of 
mycobacteria. Examples of the latter include closer social contact in confined areas 
(prisons, informal shebeens or gang hang-outs) necessitated as much by need for 
clandestine use, as by the social context and importance of cannabis smoking; and 
the sharing of joints or pipes. Biological explanations include impairment of host 
defence mechanisms from the constituents of cannabis. The latter has been 
proposed as the central hypothesis in the relationship between tobacco and 
tuberculosis. The mechanisms proposed are explored further below. 
Twenty one percent of cannabis smokers reported past or current TB disease 
compared to 8.9% of non-cannabis smokers (p<0.001 ). Cumulative exposure of 
cannabis of > 70 joint years had the strongest association with past/present TB 
(roughly equivalent to 20 cigarette pack years with respect to bronchial mucosa 
damage). More than a quarter (25.3%) of cannabis smokers had this level of 
exposure. After adjusting for known risk factors, this risk was double that of tobacco 
smoking of >20 pack years (OR 3.2; Cl: 1.8 - 5.6 versus OR 1.7; Cl: 1.1 - 2.6) 
There was no evidence of a significant interaction between tobacco and cannabis 
suggesting that they are both independent risk factors. 
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Temporal relationship between exposures and tuberculosis. 
A significant uncertainty in the current study is the temporal relationship between 
cannabis smoking and both infection and the development of active disease. Since 
there is no clinical marker useful for timing the date of infection, nor even the onset 
of disease in a retrospective survey (and particularly since the latter may develop 
insidiously over months or even years), the questionnaire responses do not permit 
scrutiny of the temporal associations of these outcomes with smoking. It is thus 
possible that the outcome may have occurred at any time before or after the 
exposure. Indeed, few host variables (such as sex and genetic influences) may be 
viewed as constant risk variables, and even these may be influenced by time if, for 
example, they only confer risk in a particular age-group. 
The cross-sectional study design measures risk factors and outcomes at the same 
time, and therefore cannot support causality. This would be more likely to be 
supported by longitudinal studies where the outcome is not yet present and thus is 
much less likely to "cause" the risk factor (the direction of effect may be clearer). 
For example, in this study it is of concern whether current income or current 
education confers risk on past TB disease. Environmental variables such as 
socioeconomic status, smoking, incarceration and BMI, alcohol use and 
occupational exposure may all be subject to change in either direction. In addition, a 
cumulative increase in risk may occur over time with smoking. An attempt to 
address this has been made by using cumulative exposure variables for both 
cannabis and tobacco. 
In assessing the public health impact of cannabis smoking, the population 
attributable fractions (PAF) for >70 joint years exposure was 5.6%. It should be 
noted that PAFs may be inaccurate tools and it is controversial whether they are a 
good measure of population impact as they can be non-additive, time insensitive 
etc. 103 The assumptions made are that they are completely adjusted for 
confounders, and that the association is causal which is not often the case, 
especially in cross sectional studies. However, PAFs are useful in that they deliver 
broad public health messages, but one has to be wary of interpreting them by saying 
that a certain percentage of tuberculosis is "due to" cannabis smoking. 103 
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5.3.2. Relationship of cannabis smoking and tuberculosis infection 
There was a very high background prevalence of tuberculosis infection in this 
community (76% of persons aged ~ 15 years). However, 87.8% of cannabis 
smokers had TB infection vs. 76.1 % of non cannabis smokers. There was no 
association between TB infection and cannabis smoking in the model which used 
joint years to assess cumulative cannabis exposure (it is confounded by 
incarceration). This could be owing to the fact that most persons in this community 
acquire TB infection early, before there is time for significant cumulative cannabis 
exposure. However, this argument does not suffice for tobacco smoking, which has 
a persistent response in both the presented (Chapter 4) and alternative models 
(Appendix 3). However, the finding of an association of both tobacco smoking and 
cannabis smoking with tuberculosis is plausible because of similarities between both 
types of smoke, at least with respect to their effects on the lungs. 
Other factors 
Firstly, imprisonment had the strongest association with TB infection in the adjusted 
analysis (OR 3.6; Cl: 1.8 - 7.1 ).There was a high rate of reported imprisonment in 
men in this community of 16.7% as a result of juvenile gang warfare, general 
lawlessness in young men part of a social problem resulting in imprisonment. 
Exposure to cannabis and habit formation is common in prisons apart from the other 
known factors that lead to TB infection in prisons. The issue of confounding by 
incarceration is interesting. Former cannabis smoking was associated with 
tuberculosis infection (OR 2.0; Cl: 1.1 - 3.6) in an alternative model which did not 
adjust for imprisonment. It is clear that imprisonment is a confounder for cannabis 
smoking, but one has to also consider the converse in that cannabis smoking may 
be a confounder for imprisonment as it is illegal and also associated with other 
reasons for imprisonment. However, for TB infection, imprisonment retains its 
significance in all models. 
The WHO reports the following factors that assist the spread of TB in prisons: 
Foremost are overcrowding and poor ventilation and high turnover of prisoners. 104 In 
addition, late case detection, lack of isolation and inadequate treatment are also 
contributors. Poor nutrition, physical and psychological stress may also weaken the 
immune response to mycobacterium tuberculosis. It is also common that many 
persons come to prison already infected. In some countries, many detainees 
become infected during pre-trial detention. 104 
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There are human rights issues regarding imprisonment. Sentencing an individual to 
a prison where he/she is more likely to contract a potentially lethal disease may 
contravene the basic human right to life. 104 Alternatives to imprisonment need to be 
considered by governments in order to decrease tuberculosis transmission. 
Secondly, alcohol abuse is a problem in Ravensmead and Uitsig. The density of 
informal taverns is seventeen per square kilometre.
91 A national survey reported that 
30% of women and 33% of men in the Western Cape Province who report current 
alcohol use are risky drinkers (~3 drinks per day in women and ~5 drinks per day in 
men). 10 
It is possible that the current study lacks sufficient power to show an association 
with alcohol - the univariate analysis showed an association, but not the adjusted 
analysis, or that the effect of alcohol is confounded by tobacco. In addition, the 
classification of the alcohol variable was rather crude which would also bias the 
results towards the null (this phenomenon is also seen with other crude 
questionnaire measures of variables such as general occupational dust exposure). 
In addition reporting bias and sharing of alcohol amongst multiple persons made the 
accurate quantification of data difficult. The analysis did not take quantity into 
account, which is a significant limitation. 
HIV status is another important risk factor to consider, but was not considered in this 
study owing to logistic constraints and the relatively low prevalence of HIV infection 
in this community at the time of the study. The population prevalence of HIV was 
likely to be lower than that of the 15-45 year old group of pregnant women in which it 
was reported (antenatal survey). HIV is one of the most important risk factors in the 
South African setting, and has been associated with atypical signs and symptoms 
and extrapulmonary dissemination. 105 HIV infected persons are at an extremely high 
risk of activating latent disease. In addition, the issues of anti-TB drug resistance 
related to the HIV epidemic and significant drug interactions associated with highly 
active anti-retroviral therapy (HAART) need to be addressed by public health 
systems. 
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5.4. Proposed mechanisms for the association of cannabis smoking 
with TB: 
5.4.1. Droplet spread 
Sharing of joints, pipes and waterpipes is the first mode of spread. Cannabis pipe 
and makeshift pipe ("witpyp" or white-pipe) smoking in particular is a greater risk 
factor. This may be for more than one reason. Cannabis may be mixed with 
tobacco, conferring increased risk and may also be smoked in a social context 
where transmission in the study areas has been shown to be higher. The prevalence 
and risk conferred by adding methaquolone is not known. Drinking in informal 
taverns (shebeens) has been identified as a risk factor for tuberculosis.
80 Previously 
treated smear-positive TB cases from Ravensmead and Uitsig form more than half 
of the prevalent smear-positive cases. This is considered to be due to reinfection 
rather than reactivation, as confirmed by DNA fingerprinting studies.
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Secondly, smoking in enclosed spaces such as cars, bars and rooms where 
ventilation is deliberately limited, allows for rebreathing of cannabis smoke and 
potentially also droplet nuclei for long periods of time in greater amounts. Thirdly, 
cannabis smoking causes cough, which further improves the potential transmission 
of organisms in enclosed spaces.85 Better enabling the routes of transmission of 
tuberculosis has been the main hypothesis explored in the literature. However, 
immunosuppressive mechanisms may also be potential factors in the transmission 
of infection and expression of disease. 
5.4.2. Host-defence mechanisms 
Considering that the constituents of cannabis smoke are very similar to that of 
tobacco smoke, it is not surprising that cannabis may also be a risk factor for 
tuberculosis. Exposure to any smoke lowers local bronchial immunity, cellular 
immunity and antibody production, therefore possibly raising susceptibility to 
infection. For instance, exposure to biomass smoke and passive tobacco smoke 
increases the risk of acute respiratory infection in children.67 
b 
The differing ingredient of THC is also implicated in impairment of the immune 
response. The number of cigarettes smoked differs to the number of joints smoked, 
but it is thought that a smaller number of joints are related to a greater effect on the 
lungs. Features such as deeper inhalation, longer retention times and absence of 
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filtration result in a greater deposition of tar deposits compared to tobacco 
smokers. 77 
Cannabis is responsible for a wide spectrum of impairment of host defences, any or 
all of which may contribute to the lowering of defences to mycobacterium 
tuberculosis, particularly in endemic areas and even more so in hosts with other 
predisposing factors. Outbreak investigations have shown that persons with 
seemingly little other predisposing factors are at a greater risk for TB disease and 
infection, as seen where cannabis smoking contacts had a higher rate of infection 
than non cannabis smoking contacts. 81 
The histological changes that occur are a loss of ciliated epithelium and replacement 
by mucus secreting surface epithelial cells.
108 The first line of defence of the lung is 
thus impaired67 (the mucociliary escalator), thus potentially predisposing to lower 
respiratory infection, which includes tuberculosis. 
Alveolar macrophages are the main cells in the lung's immune response against 
infection and form the second line of defence. 
77 There is a wide spectrum of effects 
on alveolar macrophages which support the possibility of cannabis smokers being 
more predisposed to tuberculosis. A review by Tashkin et al (2005) summarises the 
findings from studies of alveolar macrophage function.
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These include: 
• "Impairment in fungicidal activity against Candida" spp. in alveolar macrophages 
from both cannabis smokers and tobacco smokers.
109 110 
• "Impairment in phagocytosis and bacteriocidal activity against staphylococcus 
aureus by alveolar macrophages" from cannabis smokers but not tobacco 
smokers. 109The number of bacteria phagocytised and the rate of phagocytosis 
are both affected. 67 
• "Reduction in basal superoxide production by alveolar macrophages" from 
cannabis smokers. Tobacco smoking causes the opposite effect. 1
10 
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• "Impairment in generation of nitric oxide by alveolar macrophages from cannabis 
smokers (but not tobacco smokers) paralleling their impairment in bacteriocidal 
activity." 111 
• "Reduction in generation of proinflammatory cytokines, including tumour 
necrosis factor-alpha (TNF- alpha) and granulocyte macrophage-colony 
stimulating factor (GM-CSF), by alveolar macrophages" from cannabis smokers 
when stimulated with bacterial lipopolysaccharide. 109 
Tashkin et al (2005) also suggest that a clinical implication of the impairment in 
alveolar macrophage function is that cannabis smokers may be at greater risk of 
pneumonia. 74 As tuberculosis is a common respiratory infection especially in 
endemic areas, it is likely to be a possible agent. This predisposition to pulmonary 
infection may occur especially in patients who are immunocompromised e.g. HIV 
infection. Opportunistic infection in HIV positive patients has been associated with 
cannabis smoking.67 There are a few case reports of invasive aspergillosis in 
patients with AIDS. 112 However, the nature and mechanism of infection from 
mycobacteria may differ from that of other bacteria, and thus requires further study. 
Another area of interest that needs to be elucidated is the role of cannabis smoke in 
the TH1/TH2 balance - two mechanisms that are critical in determining both 
infection and disease. 
5.5. Public Health policy 
The relatively high prevalence of cannabis smoking is concerning. Public health 
efforts to lower the prevalence of cannabis smoking may reduce the prevalence of 
TB and should be pursued. Promotion of smoking cessation could have an impact 
on tuberculosis. Education about the harmful effects of cannabis may help to inform 
the public and assist in both highlighting the risks and reducing other cannabis-
related health effects such as chronic bronchitis and trauma. This can be achieved 
by use of the popular media (TV infomercials, documentaries, magazines, 
newspapers), as has been done with tobacco smoking in some developed countries. 
Secondly there is a need for effective anti-smoking-initiation interventions 
addressing both tobacco and cannabis, directed at schools and tertiary institutions, 
as few people start smoking after age 19 after which there are low levels of 
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quitting. 113 Further research examining factors that initiate, perpetuate and entrench 
smoking behaviour in South Africa and particularly in the Western Cape, may assist 
in the promotion of smoking cessation. 
5.6. Dissemination 
This study will be complied into a paper which will be submitted for publication in a 
peer reviewed journal dedicated either to respiratory medicine or to tuberculosis, 
such as the European Respiratory Journal or International Journal of Tuberculosis 
and Lung Diseases respectively. Findings from this study will also be presented at 
the American Thoracic Society Meeting in San Francisco, May 2007 and at the 
Congress of the International Union Against Tuberculosis and Lung Diseases in 
Cape Town in November 2007. Relevant persons at the local, provincial and 
national Department of Health will be informed of these findings via an Executive 
Summary and formal report. 
5.7. Concluding remarks 
This is the first population-based study to examine cannabis smoking as a risk factor 
for both tuberculosis disease and infection. This study population was appropriate 
for the exploration of the hypothesis owing to a high prevalence of both the 
exposure and outcome. In addition there was a sufficient sample size with which to 
perform multiple logistic regressions adjusting for various other risk factors. 
This study provides further impetus for the promotion of smoking cessation as an 
important public health measure and suggests that anti-smoking health promotion 
and interventions need to be inclusive of both tobacco and cannabis. A target group 
for potential intervention (anti-initiation) would be the under 15 age group, as most 
smoking is initiated prior to this age. Persons in all other age groups, and particularly 
men would benefit from a smoking cessation service. 
Tuberculosis, apart from being major cause of mortality, has been shown to have 
lasting effects in terms of respiratory morbidity. TB patients are not the only persons 
who would benefit from smoking cessation. All smokers would benefit from smoking 
cessation for a myriad of reasons - this study suggests another reason. However, 
the social and environmental causes of tuberculosis need to be addressed if any 
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headway is going to be made in quelling the epidemic, as control programs alone 
are insufficient. 
The cumulative effect of cannabis smoking was found to be an independent risk 
factor for tuberculosis disease. This finding provides further evidence that cannabis 
smoking is harmful to health. Efforts are required to combat the existing health 
burden and inform and enable progressive anti-cannabis legislation and 
enforcement in addition to anti tobacco legislation. Cannabis smoking is a risk factor 
that must be considered in future studies of tuberculosis disease and infection. 
Repeated investigation of this hypothesis in varied settings will provide further 
information regarding the relationship between cannabis and tuberculosis. 
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APPENDIX 1 
INFORMATION SHEET FOR LUNG HEAL TH SURVEY 2002 RA VENSMEAD AND UITSIG IN 
PERSONS 15 YEARS AND OLDER IN RAVENSMEAD AND UITSIG. 
You are invited to take part in a study to determine the prevalence of TB and chest diseases in people 
living in Ravensmead and Uitsig. About 5000 people will take part. Information on the study is supplied 
in this document. A trained fieldworker will be on hand to explain the contents and answer all your 
questions. Please ensure that you understand everything contained in this document. If you decide to 
participate, you will be required to give written consent before you take part. 
Who is doing the study? 
This study is being performed by health workers of the TB Research Centre of the University of 
Stellenbosch (Tygerberg Hospital) led by Professor Nulda Beyers, and the Lung Institute of the 
University of Cape Town, led by Prof. Eric Bateman. 
Ors Du Tait Loots (tel. 021-9389177), Anamika Jithoo (021-4066877), Emma van Schalkwyk (021-
9389594) are responsible for the day- to -day running of the study. 
What is the purpose of the study? 
In spite of a good TB tracing and treatment programme in the areas of Ravensmead and Uitsig, the 
number of TB cases remains high. The purpose of this study is to determine the number of people who 
are currently or have been infected with TB, or have other forms of lung disease like asthma and 
emphysema. We will look for factors that increase the risk of developing these diseases and the effect 
of these diseases upon the community. When this survey has been completed, it is our intention to 
conduct two further studies involving smaller numbers of residents of Uitsig and Ravensmead, who are 
identified in the first study. We will invite both people without lung disease, and some with chest 
complaints, to take part in the later studies. Separate information pamphlets and consent forms will be 
provided for these studies. 
What is TB? 
Tuberculosis (TB) is an infectious disease caused by bacteria (germs) which are spread through 
coughing. TB infection affects mainly the lungs, but can also affect other parts of the body, such as the 
lining of the brain (meningitis), and glands. The areas of Uitsig and Ravensmead, like other parts of the 
Western Cape has a higher number of TB cases than most other parts of South Africa. In spite of a 
good programme for tracing and treating persons with active TB infection, many persons with TB are not 
diagnosed quickly, and go on infecting other people, including friends and family without knowing it. 
Early infection with the organism can be detected with a skin test, sputum (phlegm) examination, and 
chest X-Ray. These will be performed on all that enter the study. 
Other Lung Diseases that will be studied? 
We will be asking questions and looking at X-Rays for signs of other lung diseases like asthma, chronic 
bronchitis and emphysema. We will also ask questions about your home, habits and work that might 
have an effect on your lungs. We will also look for evidence of lung damage caused by TB. In this way 
we will be able to assess how much of a problem lung diseases are in your community. 
This research proposal has been approved by the Medical Ethics Committee (Research Ethics) 
of the Universities of Stellenbosch and Cape Town and is being performed with the permission 
of the Health Department of the City of Cape Town 
Participation in this study is strictly on a voluntary basis. You are free to withdraw from this study at any 
stage, without any consequences for you. No financial reward will be given to any persons taking part in 
this study. 
Are there any risks for people who take part in this survey? 
Taking part in this study does not pose any severe risks to you or your family. However, the following 
will be required of those taking part: 
1) You will be asked to sign a consent form after you have read and understood this information 
leaflet. You will be given an original copy of this leaflet and the consent form to keep. 
2) You will be asked to complete (with the help of a trained interviewer) a detailed questionnaire 
about your health 
3) A TB skin test, called the Tuberculin test, will be performed on all that take part. In about 70% 
of persons it may form a red, slightly tender lump on the upper arm, at the injection site, within a 
day, which could last for several days, up to two weeks. Occasionally, it may blister, or form a 
shallow sore (ulcer), or cause tender glands under the arm. A health worker will record the 
result of the test after 3 days, when the reaction is strongest. If necessary, shall be will provided 
some cortisone cream to rub on the area to reduce the pain and swelling. 
4) You will be given an appointment and transport to attend the Tygerberg Hospital X-Ray 
Department for a chest X-Ray within a few days or weeks of completing the questionnaire. At 
this visit your arm will be examined for a scar from previous TB vaccination. Your height and 
weight will also be recorded. You will then have a chest X-Ray. If you are female, in privacy, 
you will be asked if you are pregnant, and if so, your abdomen will be covered by a lead shield, 
to prevent your baby from being exposed to the X-Ray.The chest X-Ray will be reported on by 
experienced specialists. The radiation risk of a standard chest X-Ray is very small. 
5) You will be asked to try and cough up some phlegm for examination for TB organisms. 
What is the benefit for you, of taking part in this study? 
The information gained from this study will be used to provide suggestions for improving health services. 
(Community Health Centres, hospitals, medications etc.) 
This study may benefit you if you have a lung problem of which you are not aware. 
What will happen if these tests show that you have a lung problem? 
After you have completed the questionnaire, the answers will be screened within days for symptoms 
that suggest lung disease that needs immediate attention. Such persons will be contacted within days, 
to have a chest X-Ray and be referred to a doctor at either the local Community Health Centre, or if 
they prefer, to their private doctor. If considered necessary, they might be referred to the Lung Clinics at 
either Tygerberg or Groote Schuur Hospitals. If the X-Ray or phlegm examination shows TB, you will be 
referred to the local TB Clinic for treatment. 
Confidentiality of information and privacy of the participant 
All personal information obtained during this study will remain strictly confidential. 
The answers will be transferred to a computer, but your name will not be included, and you will be 
identified by a coded number. No information about individuals will be released to any other parties but 
the research team, without your further consent. When the results of research are published( for 
example, in medical journals), no personal details that might identify individuals, or individual 
households will be included. Completed questionnaires will be stored in a safe place. 
Thank you for reading this information sheet. If you have any questions, please ask them now. 
The interviewer will be pleased to answer them. If you wish to take part, please read and sign the 
2 consent forms. 
Please keep this information sheet and a copy of the consent form in a safe place, for your 
records. 
C:/MyDoc.Jithoo/AdultC1 (6-5-02).doc (Final corrections dated 7-5-02) 
INFORMED CONSENT FORM FOR THE LUNG HEALTH SURVEY 
(FOR PERSONS AGE 15 YEARS AND OLDER) 
• I confirm that I have read the information sheet, and that the information and 
procedures involved in my taking part in the survey have been explained to me. 
• I confirm that I have had the opportunity to ask questions about the survey and 
that I am satisfied with the answers and explanations that have been provided. 
• I have been given time and opportunity to read the information carefully, to 
discuss it with others and to decide whether or not to take part in this survey. 
• I agree to take part in the survey. 
Subject's signature: __________________ date ___ _ 
Subject's name: __________________ (please print) 
The person who conducts the informed consent discussion must also sign and date 
this form. 
Signature: __________________ date ___ _ 
Name: __________________ (please print) 
Signature of witness, if applicable. 
Witnessed by: (print name): ________________ _ 
Signature of Witness: date ------------- -----
APPENDIX 2 
I 3091 •••••••••••••••••••••••••••••••• ~~o-
Please read these 3 instructions carefully before completing the questionnaire: 
1 Do not write anywhere outside the spaces provided. 
2 Indicate correct answers in check boxes with an X, i.e. IZl 





Today's date cl cl/ m ml Y Y Y ,.I 
Sex O Male 0 Female 






8 If you do not know your date of birth, what was your age on your last birthday? D years 
9 How many years have you lived in the present home? 
10 How many years have you lived in Ravensmead/Uitsig? 
11 Where did you live before this? 





0 Employed by government 
0 Employed in private sector 
0 Casual employment, specify: 
If unemployed go to Question 14. 
If you are employed, please state the nature of your job. 
0 Street vendor O Taxi driver 0 
D Hair dresser D Child minder D 
0 Shop owner O Health care worker 0 
What is your usual monthly income( from all sources)? 
0 Less than R 500 0 R 3 000-R 4 000 
0 R 500-R 1 000 0 R 4 000-R 5 000 
0 R 1 000-R 2 000 0 R 5 000-R 6 500 
0 R 2 000-R 3 000 0 R 6 500-R 8 000 
15 What level of education did you reach? 
D years 
I I years 
Unemployed 
n Not seeking work 




D Disability grant for chest disease 
n Disability grant for other disease 
0 Child support grant 
Factory worker 
Office worker 
Other (Please specify): 
0 R 8 000-R 10 000 
0 R 10 000-R 13 000 
0 Greater than 13 000 
Highest grade completed: D D Initiated tertiary education 
16 What is your marital status? 
I 
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We are now going to ask you some questions about chest problems .... 
17 Has a doctor/health worker ever told you that you have (check all that apply): 
0 Heart trouble? 






0 Other chest trouble? Specify: 
18 If you have had TB, when and where was it treated? 
Start of treatment End of treatment 
1 
I m «.I y y Y YI m ml Y Y Y YI 
2 I m m I Y Y Y YI m «.I Y Y Y YI 
3 
I m ,J Y Y Y YI m «.I Y Y Y YI 
19 Do you have a cough that began recently? DY ON 
If 'yes', when did it start? I / / j 
d d m m Y Y Y Y 
20 Are you coughing up blood now or in the last month? 
Clinic/Hospital Name 
21 Have you coughed up blood in the last 12 months? Di' ON 
If 'yes', when did it start? I / / I 
dd mm YYYY 
22 Do you usually bring up any phlegm from your chest first thing in the morning in the winter? 
23 Do you usually bring up any phlegm from your chest during the day, or at night, in the winter? 
If 'no', go to question 24. 
23.1 Do you bring up phlegm like this on most days for as much as 3 months each year? 
23.2 Have you had coughing and phlegm on most days for a minimum of 3 months a year 
and for at least 2 successive years? DY ON 
24 In the last 12 months, have you had any chest illnesses that have kept you off work, 
indoors at home, or in bed? DY Ot~ 
If 'no' go to question 25. 
24.1 Did you produce phlegm with any of these chest illnesses? 
24.2 In the last 12 months, how many such illnesses, with (increased phlegm), did you have 
which lasted a week or more? D 
25 Do you ever have trouble with your breathing? 
If 'no' go to question 26. 
25.1 Do you have this trouble D Continuously, so that your breathing is never quite right? 
0 Repeatedly, but it always gets completely better? 
0 Only rarely? 
26 Are you disabled from walking by any condition other than heart or lung disease? QYQt·l 
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27 Are you troubled by shortness of breath when hurrying on the level or walking up a slight hill? DY Ot~ 
If 'no', go to Question 28. 
27 .1 Do you have to walk slower than people of your own age on the level 
because of breathlessness? DY ON 
27.2 Do you ever have to stop for breath when walking at your own pace on the level? ny ON 
27.3 Do you ever have to stop for breath after walking about 100 yards 
(or after a few minutes) on the level? DY ON 
27.4 Are you too breathless to leave the house or breathless on dressing or undressing? 
28 Have you had wheezing or whistling in your chest at any time in the last 12 months? DY Ot·l 
If 'no', go to question 29. 
28.1 Have you been at all breathless when the whistling noise was present? DY Ot~ 
28.2 Have you had this wheezing or whistling when you did not have a cold? DY ON 
28.3 Have you been woken by an attack of shortness of breath or tightness in your chest 
at any time in the last 12 months? DY Ot·l 





when you DID NOT have a cold or the flu? DY ON 
If 'no', go to question 30. 
29.1 In the last 12 months, have you_had a problem with sneezing, or a runny, or blocked nose 
when you DID NOT have a cold or the flu? DY ON 
Do you have to change your clothes or bedding because of night sweats? DY ON 
If 'yes', when did it start? I / / I 
. dd mm YYYY 
Are you troubled by fever? DY Ot·l If 'yes', when did it start? I / / I 
dd mm YYYY 
Are you losing weight? DY ON If 'yes', when did it start? I / / I 
dd mm YYYY 
Do you recall having any chest illnesses with cough and shortness of breath 
when you were a child (<12 years)? DY Ot·l 
If 'no', go to Question 34. 
33.1 Did you have such an illness repeatedly? DY Ot~ 
33.2 Did you ever sleep in a hospital for such an illness? 
33.3 Do you recall the name of the illness? DY ON If 'yes', specify: 
34 Have you smoked cigarettes for a year or longer? DY Ot~ 
If 'no', go to Question 35. 
34.1 How old were you when you started smoking? D 
34.2 Do you smoke now (within the last month)? LJY 011 
If 'no', how old were you when you stopped smoking? D 
34.3 On average, how much do you smoke or did you smoke? 
Number of cigarettes per day: I I Number of pipe bowls per day: D 
• 
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35 Have you ever smoked anything other than tobacco? DY ON If 'no', go to Question 36. 
If 'no', go to Question 36. 35.1 Have you ever smoked cannabis? DY ON 
35.2 How old were you when you started smoking cannabis? 
35.3 Do you smoke now (within the last month)? DY ON 
D 
D If 'no', how old were you when you stopped smoking? 
35.4 On average, how much do you smoke or did you smoke per day? 
Number of joints per day: D Number of pipes per day: D 
36 Have you ever worked in a job that exposed you to silica dust, or involve sand blasting, grinding, 
pottery, work in a quarry/mine or grave stone manufacturing? DY ON 
37 Have you ever been exposed to other dusts, gases, strong smells, chemicals, fumes, at work? 
If 'no', go to Question 38. 
37.1 Have you ever had to leave your job because it affected your breathing? DY ON 
38 Do you or your immediate neighbours keep pigeons/birds in a cage (not chickens)? 
39 Have you ever been told that you snore? If 'no', go to Question 40. 
39.1 According to what others have told you, please estimate how often you snore. 
n Rarely D 3 to 5 times a week 
n Sometimes D Every night or almost every night 
D Once a week O Do not know 
39.2 How loud have others said your snoring is? 
D only slightly louder than heavy breathing 
D about as loud as mumbling or talking 
0 louder than talking 
D extremely loud (can be heard through a closed door) 
0 do not know 
40 According to what others have told you, how often, if ever, do you gasp, choke, 
or make snorting sounds during sleep? 
0 never O often (at least once a week) 
0 rarely O very often(every nighUalmost every night) 
0 sometimes O Do not know 
41 According to what others have told you, how often, if ever, do you seem to have momentary periods? 
during sleep, when you stop breathing, or you breathe abnormally? 
0 never O often(at least once a week) 
0 rarely D very often( every nighUalmost every night) 
0 sometimes O Do not know 
42 Are you currently taking any medicines(including inhalers, aerosols, or tablets) 
for any chest diseases, including nasal allergies? DY ON If 'no', go to Question 43. 
42.1 For what conditions are you taking these medicines (check all that apply)? 




0 Hay fever? 
D TB? 
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42.2 Where do you receive your chest medicines? 
usually occasionally 
(check one only) (check all that apply) 
0 Community clinic 0 
LJ Private hospital 0 
0 Provincial hospital 0 
0 Pharmacy 0 
0 Private practitioner 0 
n Traditional healer n 
0 A friend 0 
43 Where do you usually go for medical care for chest problems? 
usually occasionally 
(check one only) (check all that apply) 
0 Community clinic 0 
n Private hospital D 
0 Provincial hospital 0 
0 Pharmacy 0 
0 Private practitioner 0 
LJ Traditional healer 0 
LJ A friend 0 
43.1 In the last 12 months, have you visited the above for your chest/lung disease? DY ON 
If 'yes', how many times? D 
44 Where do you usually go for emergency treatment for your chest problems? 
usually occasionally 
(check one only) (check all that apply) 
0 Community clinic 0 
0 Private hospital 0 
D Provincial hospital n 
0 Pharmacy 0 
0 Private practitioner 0 
0 Traditional healer 0 
0 A friend LJ 
45 Have you visited a hospital casualty department or emergency room 
because of your chest/lung disease in the last 12 months? DY ON 
lf'yes', how may times? D 
46 Have you spent at least one night in hospital because of your chest/lung disease 
in the last 12 months? DY ON If 'yes', how many days? D 
47 If you are currently employed, have you lost any days of work because of your chest/lung disease 
in the last 12 months? DY Ot·l If 'yes', how many days? D 
I 
I 
48 Whatever your working situation, have there been any days when you have had to give up other activities 
(e.g. looking after the children, the housework, studying) because of your chest/lung disease, 
in the last 12 months? O'l' ON 
If 'yes', how many days, on average, every month? D 
I 
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49 Do you drink alcohol? O·r ON If 'no', go to Question 50. 
50 
51 
49.1 How many days do you drink during the week (Monday to Thursday)? D 
49.2 How many days do you drink over weekends (Friday to Sunday)? D 
49.3 How much would you drink on a typical drinking day? 
Wineoml shared by D persons 
Brandy/ whisky D ml shared by D persons 
Beer oml shared by D persons 
Other alcoholic drinks D ml shared by D persons 











What amount of time do you spend on average in the following places (other than home)? 












52 What fuels are mostly used in the dwelling you spend most of your evenings? 
For Cooking For Heating 
(check one only) (check one only) 
D Wood or coke 0 
0 Gas 0 
0 Electricity 0 
0 Paraffin 0 
0 Spirits 0 
53 Have you ever spent time in a prison? If yes, please specify dates and place: 
From To Prison 
I 
,........==-~-~ 
m ml Y Y Y YI 




Alternative multivariate models 
Outcome TB disease 
Model assessing the cannabis and tobacco interaction using non, ex- and 
current cannabis and tobacco smoking 
xi:svy:logit prespast_tb i.dagga i.age cat gender cat i.smoker prison i.BMI cat 
i.educ cat tert i.wealth 
> 3 i.alc cat occ_exposure i.smoker*i.dagga ,or 
i.dagga Idagga_l-3 (naturally coded; 
i.age_categor-s Iage_categ_l-6 (naturally coded; 
i.smoker Ismoker_l-3 (naturally coded; 
i.BMI cat IBMI cat 1-4 (naturally coded; 
i.educ cat tert Ieduc cat 1-4 (naturally coded; 
i.wealth3 Iwealth3 1-3 (naturally coded; 
i.alc cat Ialc cat 0-3 (naturally coded; 
i.s-ker*i.dagga IsmoXdag #_# (coded as above) 
(running logit on estimation sample) 




IBMI cat 1 omitted) 
Ieduc cat 1 omitted) 
Iwealth3 1 omitted) 
Ialc cat O omitted) 
Number of strata 
bvNumber of PSUs 







prespast tb I Odds Ratio Std. Err. t 
Population size 
Design df 
F ( 26, 739) 
Prob> F 
P>ltl [95~ Conf. Interval] 
-------------+----------------------------------------------------------------
Idagga 2 2.375152 1.579334 1.30 0.194 . 6438657 8.761682 -
Idagga 3 3. 971371 2.319834 2.36 0.018 1.261628 12.50114 
Iage cate-2 1.946911 .4450712 2.91 0.004 1.242938 3.049599 -
Iage cate-3 2.622686 .6099185 4.15 0.000 1.661427 4.140106 -
rage_ cate-4 2.561159 .6484283 3. 71 0.000 1. 558079 4.210016 
Iage cate-5 3.119861 .7806793 4.55 0.000 1.908983 5.098805 -
rage cate-6 1.535007 . 5062877 1. 30 0.194 .8033689 2.932956 
-
gender cat 1.01394 .1627167 0.09 0.931 . 7399372 1.389407 
Ismoker 2 1.750261 .4520278 2.17 0.031 1.054193 2.905933 -
Ismoker 3 1.169106 .1861421 0.98 0.327 .8552884 1.598067 -
prison 1. 302947 .2742143 1. 2 6 0.209 .8619879 1.969483 
IBMI cat 2 .4535978 .0904306 -3.97 0.000 .3066928 .6708699 
IBMI cat 3 .3788978 .0842306 -4.37 0.000 .2449042 .5862031 
IBMI cat 4 1.911929 .3600552 3.44 0.001 1.321049 2.767099 -
Ieduc cat-2 1.392097 .2831755 1. 63 0.104 .9337837 2.075356 -
Ieduc cat-3 1.633269 .3753949 2.13 0.033 1.040171 2.564547 -
Ieduc cat-4 . 9386734 .3971825 -0.15 0.881 .4090465 2.154053 
Iwealth3 2 1.059796 .2771994 0.22 0.824 .6342047 1. 770986 
-
Iwealth3 3 1.669078 .404292 2 .11 0.035 1.037451 2.685257 -
Ialc cat 1 1.039679 .1824861 0.22 0.825 .7366441 1.467373 
- -
Ialc cat 2 1.242846 .2723687 0.99 0. 321 .8083157 1.910968 
- -
Ialc cat 3 1.089334 .3508452 0.27 0.791 . 5788649 2.049959 - -
occ exposure 1.199088 .185801 1.1 7 0.242 .8845987 1. 625383 
IsmoXda-2 2 .5586657 .4655755 -0.70 0.485 .1088079 2.868427 -
IsmoXda-3 2 . 6062653 .436802 -0.69 0.488 .1473723 2.494075 -
IsmoXda-3 3 .3263741 .1998532 -1.83 0.068 .0980981 1.085853 
-
------------------------------------------------------------------------------
. testparm IsmoXda* 






IsmoXdag 3 3 
F( 3, 762) 







Outcome: TB infection 
Model without adjusting for imprisonment 
xi:svy:logit mtxlO i.age cat gender_cat i.dagga i.smoker i.alc cat occ exposure 
i.educ cat tert i.wealth 










Ialc cat 0-3 
Ieduc cat 1-4 
Iwealth3 1-3 
(running logit on estimation sample) 
Survey: Logistic regression 
Number of strata 1 
Number of PSUs 818 
Linearized 








coded; Iage categ 1 omitted) 
-
coded; Idagga_ 1 omitted) 
coded; Ismoker 1 omitted) 
-
coded; Ialc cat 0 omitted) -
coded; Ieduc cat 1 omitted) 
coded; Iwealth3 1 omitted) 
Number of obs 3413 
Population size 2 61 78 
Design df 817 
F( 19, 799) 11. 61 
Prob> F 0.0000 
P>ltl [95% Conf. Interval] 
-------------+----------------------------------------------------------------
Iage_ cate-2 4.181028 .6762735 8. 84 0.000 3.043677 5.743381 
Iage cate-3 2.692877 .4228978 6.31 0.000 1.978531 3.665137 -
Iage cate-4 2.131814 . 3647257 4.42 0.000 1.523715 2.982599 -
_Iage_ cate-5 1.399492 .241707 1. 95 0.052 . 9971052 1.964265 
Iage cate-6 .5790874 .1169945 -2.70 0.007 .38951 .8609336 
gender cat 1.205406 .1316939 1. 71 0.088 . 972746 1.493714 
Idagga_ 2 1. 974495 .605535 2.22 0.027 1.081493 3.604861 -
Idagga 3 1.127795 .2658234 0.51 0.610 . 7100728 1.791256 
-
Ismoker 2 1.322509 .2584728 1. 4 3 0.153 .9011395 1.94091 -
Ismoker 3 1.648905 .1941524 4.25 0.000 1.308642 2.077639 -
Ialc cat 1 1.163416 .1529705 1.15 0.250 . 898772 1.505984 - -
Ialc cat 2 .9022128 .1908786 -0.49 0.627 . 5956011 1.366666 - -
Ialc cat 3 .7018007 .2011536 -1.24 0.217 .3998307 1.231832 -
occ exposure 1. 027424 .1304618 0 .21 0.831 .8007632 1.318242 -
Ieduc cat-2 .9060787 .1219807 -0. 73 0.464 .6956697 1.180127 -
Ieduc cat-3 1.255794 .2127706 1. 34 0.179 .9005018 1. 751267 -
Ieduc cat-4 .6163646 .1636642 -1.82 0.069 .3660004 1.037991 
Iwealth3 2 1.128091 .2059387 0.66 0.509 .7883562 1.614231 -
Iwealth3 3 .9826227 .1512195 -0.11 0.909 .7264369 1.329155 
------------------------------------------------------------------------------
2 
Outcome: TB infection 
Model adjusting for imprisonment 
xi:svy:logit mtxlO i.age_cat gender cat i.dagga i.smoker i.alc cat prison 
occ_exposure i.educ_cat_tert i. 










Ialc cat 0-3 
Ieduc cat 1-4 
Iwealth3 1-3 
(running logit on estimation sample) 
Survey: Logistic regression 
Number of strata 1 
Number of PSUs 817 
Linearized 








coded; Iage _categ_ 1 omitted) 
coded; Idagga_ 1 omitted) 
coded; Ismoker 1 omitted) 
coded; Ialc cat 0 omitted) 
coded; Ieduc cat 1 omitted) 
coded; Iwealth3 1 omitted) 
Number of obs 3387 
Population size 2 61 78 
Design df 816 
F( 20, 797) 11. 07 
Prob > F 0.0000 
P>[t[ [95% Conf. Interval] 
-------------+----------------------------------------------------------------
Iage_ cate-2 4.0956 . 6632641 8. 71 0.000 2.980331 5. 628214 
Iage cate-3 2.615782 .4129485 6.09 0.000 1.918776 3.565978 -
Iage cate-4 2.072322 .3583602 4.21 0.000 1.475853 2.909857 -
Iage cate-5 1. 364246 .239443 1. 77 0. 077 . 9666598 1.925358 -
Iage cate-6 .5699387 .1146197 -2.80 0.005 .3840517 .8457979 
gender cat 1.146987 .1262409 1. 25 0.213 .924131 1.423585 
_Idagga_2 1.669535 .5201368 1. 65 0.100 .9057604 3.077357 
Idagga 3 . 8921571 .2152345 -0.47 0.636 .5556258 1.432519 -
Ismoker 2 1.337695 .2621172 1. 48 0.138 .9105818 1.965147 -
Ismoker 3 1.629924 .1912924 4.16 0.000 1.294552 2.052178 -
Ialc cat 1 1.170768 .1542804 1. 20 0.232 . 9039311 1.516374 -
Ialc cat 2 .9025594 .1939048 -0.48 0.633 .5920154 1.376001 - -
Ialc cat 3 . 6286767 .1810637 -1.61 0.107 . 3571994 1.106481 -
prison 3.020794 .9465241 3.53 0.000 1.633099 5.587655 
DCC exposure . 9942735 .1274154 -0.04 0. 964 . 7731486 1.278641 -
Ieduc cat-2 . 9130833 .1233161 -0. 67 0.501 .7004562 1.190254 
Ieduc cat-3 1. 231038 .2093744 1. 22 0. 222 .8816259 1.718931 
Ieduc cat-4 . 6646113 .1820337 -1. 4 9 0.136 .3882233 1.137769 
Iwealth3 2 1.111587 .202854 0.58 0.562 . 7769205 1. 590415 -
Iwealth3 3 .9373466 .1453793 -0.42 0. 677 .6913303 1.27091 -
3 
Outcome: TB infection 
Model assessing the interaction of cannabis with imprisonment 
xi:svy:logit mtxlO i.age_cat gender_cat i.dagga*prison i.smoker i.alc cat 
occ_exposure i.educ_cat tert i 
> .wealth3 prison,or 
i.age_categor-s Iage_categ 1-6 
i.dagga Idagga_l-3 
i.dagga*prison IdagXpriso_# 
i.smoker Ismoker 1-3 
i.alc cat Ialc cat 0-3 
i.educ cat tert Ieduc cat 1-4 
i.wealth3 Iwealth3 1-3 
(running logit on estimation sample) 
Survey: Logistic regression 
Number of strata 
Number of PSUs 













Idagga 1 omitted) 
Ismoker_l omitted) 
Ialc cat O omitted) 
Ieduc cat 1 omitted) 
Iwealth3 1 omitted) 
Number of obs 3387 
Population size 26178 
Design df 816 
F( 22, 795) 10.33 
Prob > F 0.0000 
t P>ltl [95 Conf. Interval] 
-------------+----------------------------------------------------------------
Iage cate-2 4.095797 -
Iage_ cate-3 2.614796 
Iage cate-4 2.074686 -
Iage_ cate-5 1.366791 
Iage_ cate-6 .5714821 
gender cat 1.141959 
_Idagga_2 2.210913 




Ismoker 2 1.333033 -
Ismoker 3 1.623164 -
Ialc cat 1 1.164124 - -
Ialc cat 2 .8862849 
-
Ialc cat 3 . 6029271 -
occ exposure .9982665 
Ieduc cat-2 . 9040511 -
Ieduc cat-3 1.221171 -
Ieduc cat-4 .6606827 
Iwealth3 2 1.116843 
Iwealth3 3 .943157 
testparm IdagXpris* 



































4 .22 0.000 
1. 78 0.076 
-2.78 0.006 
1. 20 0.230 
2.17 0.030 

















1. 478075 2.912113 
.968212 1.929452 
.3849367 .8484297 
.9194943 1. 418248 
1.078076 4.534128 
.528623 1.510478 
1. 771358 13.49709 






.3398551 1. 069636 




. 7798701 1.599419 
.6951047 1.279728 
4 
Outcome: TB infection 
Model assessing the joint-year/prison interaction 
xi:svy:logit mtxlO i.age_cat gender cat l.Jointpipe years cat i.packyear cat 
l.Jointpipe years cat*priso 
> n prison i.alc cat occ_exposure i.educ_cat_tert i.wealth3 ,or 
i.age_categor-s Iage_categ_l-6 
i.jointpipe_y-t Ijointpipe 0-3 
i.packyear cat Ipackyear 0-3 
i.-s_cat*prison IjoiXpriso_# 
i.alc cat Ialc cat 0-3 
i.educ cat tert Ieduc cat 1-4 
i.wealth3 Iwealth3 1-3 
(running logit on estimation sample) 
Survey: Logistic regression 
Number of strata 




mtxlO I Odds Ratio Std. Err. 
(naturally coded; Iage_categ 1 omitted) 
(naturally coded; IJointpipe O omitted) 
(naturally coded; Ipackyear O omitted) 
(coded as above) 
(naturally coded; Ialc_cat_O omitted) 
(naturally coded; Ieduc cat 1 omitted) 
(naturally coded; Iwealth3 1 omitted) 
Number of obs 3357 
Population size 26178 
Design df 816 
F( 25, 792) 8.83 
Prob > F 0.0000 
t P>ltl [95% Conf. Interval] 
-------------+----------------------------------------------------------------
Iage_cate-2 4.088618 .6637911 8.67 0.000 2.972884 5.623093 
Iage_cate-3 2.519595 .4072778 5.72 0.000 1.834572 3.460405 
Iage cate-4 2.024505 .3633349 3.93 0.000 1.423404 2.879451 
Iage_cate-5 1.299858 .2326662 1.47 0.143 .914766 1.847064 
Iage cate-6 .5567577 .1116796 -2.92 0.004 .3755525 .8253949 
gender cat 1.109564 .1226639 0.94 0.347 .8931226 1.378459 
_Ijointpip-1 1.28096 .3791758 0.84 0.403 .7164701 2.290199 
I]Olntpip-2 1.024109 .6112743 0.04 0.968 .3173383 3.304985 
I]Olntpip-3 1.880886 1.096389 1.08 0.279 .599033 5.905739 
Ipackyear-1 1.38213 .1685604 2.65 0.008 1.087889 1.755954 
_Ipackyear-2 2.174998 .5023414 3.36 0.001 1.382203 3.42252 





Ialc cat 1 
Ialc cat 2 
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